Tropical Dermatology — MCQs

Q: Which of the following conditions is characterized by the sign of the groove?

Lymphogranuloma venereum. **Explanation:** **Lymphogranuloma venereum (LGV)** is caused by the **L1, L2, and L3 serovars of *Chlamydia trachomatis***. The "Sign of the Groove" (Greenblatt’s sign) is a pathognomonic clinical finding in the secondary stage of LGV. It occurs when the inguinal and femoral lymph nodes enlarge simultaneously, separated by the rigid **inguinal ligament**. This creates a visible depression or "groove" between the two groups of inflamed lymph nodes. **Analysis of Incorrect Options:** * **B. Granuloma Inguinale (Donovanosis):** Caused by *Klebsiella granulomatis*. It presents with painless, beefy-red, velvety ulcers. It is characterized by "pseudobuboes" (subcutaneous granulation tissue) rather than true lymphadenopathy. * **C. Syphilis:** Primary syphilis presents with a painless, indurated "hard chancre." While it causes bilateral inguinal lymphadenopathy, the nodes are discrete, rubbery, and do not form a groove. * **D. Chancroid:** Caused by *Haemophilus ducreyi*. It presents with painful, soft ulcers and painful inflammatory buboes that are usually unilateral and may suppurate, but they do not form the characteristic groove sign. **High-Yield Clinical Pearls for NEET-PG:** * **Stages of LGV:** Primary (painless papule/ulcer), Secondary (Inguinal syndrome with the Groove sign), and Tertiary (Genito-anorectal syndrome/Elephantiasis). * **Diagnosis:** Frei test (historical), NAAT (current gold standard), and **Donovan bodies** (safety-pin appearance) are seen in Donovanosis, NOT LGV. * **Treatment:** Doxycycline (100 mg BID for 21 days) is the drug of choice for LGV.

Q: A young tourist presents with an erythematous lesion on the cheek with central crusting after visiting a region endemic for a specific protozoal infection. What is the likely dermatological condition?

Cutaneous Leishmaniasis. ### Explanation **Correct Option: A. Cutaneous Leishmaniasis** Cutaneous Leishmaniasis (CL), often referred to as "Oriental Sore" or "Delhi Boil," is caused by the protozoan *Leishmania* species and transmitted by the bite of an infected **female sandfly (*Phlebotomus*)**. The classic presentation begins as a small erythematous papule at the inoculation site (usually exposed areas like the face), which evolves into a nodule and eventually develops **central crusting** or ulceration with a raised, indurated border. The history of travel to an endemic region is a crucial diagnostic clue. **Why Incorrect Options are Wrong:** * **B. Systemic Lupus Erythematosus (SLE):** Typically presents with a "malar rash" (butterfly distribution) that spares the nasolabial folds. It is an autoimmune condition, not associated with travel to protozoal endemic areas or central crusting. * **C. Lupus Vulgaris:** This is a chronic form of cutaneous tuberculosis. While it affects the face, it typically presents as "apple-jelly" nodules on diascopy and follows a very chronic, progressive course rather than an acute post-travel presentation. * **D. Chilblains (Pernio):** An inflammatory response to cold, damp conditions. It presents as itchy, purple-red bumps on fingers or toes, not as a crusted facial lesion following tropical travel. **High-Yield Clinical Pearls for NEET-PG:** * **Vector:** Female Sandfly (*Phlebotomus*). * **Diagnosis:** Skin biopsy or slit-skin smear showing **LD bodies** (Leishman-Donovan bodies) within macrophages. * **Treatment of Choice:** Intralesional or systemic **Sodium Stibogluconate** (Pentavalent antimonials) or Miltefosine. * **Volcano Sign:** The appearance of a crusted ulcer with a central pit is often described as the "volcano sign."

Q: What is characteristic of donovanosis?

Pseudolymphadenopathy. **Donovanosis (Granuloma Inguinale)** is a chronic, progressive bacterial infection caused by the intracellular Gram-negative organism *Klebsiella granulomatis*. ### **Explanation of the Correct Answer** **A. Pseudolymphadenopathy:** This is the hallmark of Donovanosis. Unlike other STIs, the infection does not typically involve the regional lymph nodes. Instead, the subcutaneous granulation tissue spreads along the inguinal folds, causing firm, non-tender swellings that mimic enlarged lymph nodes. These are called **"pseudobuboes."** ### **Why Other Options are Incorrect** * **B. Penicillin is used for treatment:** Penicillin is ineffective. The CDC-recommended first-line treatment is **Azithromycin** (1g weekly or 500mg daily for at least 3 weeks). * **C. Painful ulcer:** Donovanosis is classically **painless**. It presents as beefy-red, friable (bleeds easily on touch) ulcers with rolled-out edges. Pain only occurs if there is secondary bacterial superinfection. * **D. Suppurative lymphadenopathy:** This is characteristic of **Lymphogranuloma Venereum (LGV)** or **Chancroid**, where true fluctuant buboes form. Donovanosis lacks true lymph node involvement. ### **High-Yield Clinical Pearls for NEET-PG** * **Donovan Bodies:** Diagnosis is confirmed by seeing "safety-pin" appearing organisms within large macrophages on a Giemsa or Wright stain (crush smear). * **Clinical Appearance:** Often described as "beefy-red" granulation tissue with a "velvety" texture. * **Extragenital Involvement:** Can occur in the mouth, liver, or bone via autoinoculation or hematogenous spread. * **Mnemonic:** Remember the **"4 Ps"** of Donovanosis: **P**ainless, **P**rogressive, **P**seudobuboes, and **P**olymorphic (various clinical types like ulcerogranulomatous, hypertrophic, etc.).

Q: What is the treatment for Lucio phenomenon?

Exchange transfusion. **Explanation:** **Lucio Phenomenon** is a rare, life-threatening variant of Type 2 Lepra Reaction (ENL) seen exclusively in patients with diffuse lepromatous leprosy (Lucio leprosy). It is characterized by necrotizing vasculitis of small vessels, leading to extensive, jagged, purpuric macules and large areas of skin necrosis. 1. **Why Exchange Transfusion is Correct:** The pathogenesis involves severe hypercoagulability, immune complex deposition, and massive bacterial load leading to vascular occlusion. **Exchange transfusion** (or plasmapheresis) is considered the treatment of choice in severe, life-threatening cases because it rapidly removes circulating immune complexes, inflammatory cytokines, and helps correct the underlying coagulopathy. 2. **Why Other Options are Incorrect:** * **Steroids (A):** While used in standard ENL, they are often insufficient as monotherapy for Lucio phenomenon due to the primary mechanism being thrombotic infarct rather than simple inflammation. * **Lenalidomide (B):** This is a derivative of Thalidomide. While Thalidomide is the drug of choice for standard ENL, it is notably **ineffective** in Lucio phenomenon. * **Clofazimine (C):** It has anti-inflammatory properties used in chronic ENL but acts too slowly to manage the acute, necrotic crisis of Lucio phenomenon. **Clinical Pearls for NEET-PG:** * **Geographic association:** Most common in Mexico and Central America. * **Clinical hallmark:** "Median-sized" necrotic ulcers with a jagged border. * **Histopathology:** Shows colonization of endothelial cells by *M. lepromatosis* or *M. leprae*, resulting in endothelial proliferation and thrombosis. * **Key distinction:** Unlike ENL, Lucio phenomenon typically lacks systemic symptoms like high fever in the early stages, focusing instead on cutaneous infarcts.

Q: A child from Bihar presents with hypopigmented patches on the face. What is the most likely diagnosis?

Leprosy. **Explanation:** In the context of NEET-PG, the geographical location provided in a clinical stem is a critical diagnostic clue. **Bihar** is a highly endemic region for **Leprosy (Hansen’s Disease)** in India. In an endemic area, any hypopigmented patch in a child should be considered Leprosy until proven otherwise. The diagnosis is clinically supported by the presence of sensory loss (anesthesia/hypoesthesia) within the patch and/or thickened peripheral nerves. **Analysis of Options:** * **Leprosy (Correct):** The most common presentation in children is a solitary, ill-defined hypopigmented patch (Tuberculoid or Indeterminate spectrum). The epidemiological link to Bihar makes this the most likely diagnosis for exam purposes. * **Pityriasis alba:** This also presents as hypopigmented patches on the face of children, often associated with atopy. However, the patches usually have fine scaling and lack the sensory loss or nerve involvement characteristic of Leprosy. * **Vitiligo:** This presents as "depigmented" (chalky white) macules rather than "hypopigmented" patches. The borders are usually well-defined, and sensation remains intact. **Clinical Pearls for NEET-PG:** * **Cardinal Signs of Leprosy:** 1. Hypopigmented/erythematous patches with definite loss of sensation. 2. Thickened/tender peripheral nerves. 3. Positive skin smear for Acid Fast Bacilli (*M. leprae*). * **Differential Diagnosis:** For a hypopigmented patch on the face, always consider *Pityriasis versicolor* (fungal, "spaghetti and meatballs" appearance on KOH) and *Post-inflammatory hypopigmentation*. * **High-Yield Fact:** The most common nerve involved in Leprosy is the **Ulnar nerve**, but the most common nerve involved in the face is the **Zygomatic branch of the Facial nerve** (leading to lagophthalmos).

Q: What is the early reaction of the Lepromin test known as?

Fernandez reaction. The **Lepromin test** is a skin test used to measure the cell-mediated immunity (CMI) of a patient against *Mycobacterium leprae*. It is not a diagnostic test for leprosy but is used for classification and prognosis. ### Explanation of the Correct Answer The **Fernandez reaction** is the **early reaction** observed in the Lepromin test. It occurs **48 to 72 hours** after the intradermal injection of lepromin. It is a Type IV (delayed-type) hypersensitivity reaction to the soluble bacterial proteins. A positive Fernandez reaction indicates that the individual has been previously sensitized to *M. leprae* antigens. ### Why Other Options are Incorrect * **Late Mitsuda reaction (Option A):** This is the **late reaction** observed **3 to 4 weeks** after the injection. It represents a granulomatous response to the bacillary components of the lepromin. It is highly positive in Tuberculoid leprosy (TT) and negative in Lepromatous leprosy (LL). * **Early Mitsuda reaction (Option C):** This is a misnomer. The Mitsuda reaction is inherently a late-phase reaction. * **First lepromin reaction (Option D):** This is not a standard medical term used to describe the phases of the Lepromin test. ### High-Yield Clinical Pearls for NEET-PG * **Prognostic Value:** A positive Mitsuda reaction indicates strong CMI and a better prognosis (Tuberculoid end of the spectrum). * **Classification:** Lepromin test is **Negative** in Lepromatous Leprosy (LL) due to anergy and **Positive** in Tuberculoid Leprosy (TT). * **Antigen Types:** * *Lepromin H (Hayashi):* Derived from human leproma. * *Lepromin A (Armadillo):* Derived from armadillo-grown bacilli (more commonly used today). * **Memory Aid:** **F**ernandez = **F**ast (48-72 hours); **M**itsuda = **M**onth (approx. 3-4 weeks).

Q: Which of the following are clinical features of Erythema nodosum leprosum?

Fever. **Erythema Nodosum Leprosum (ENL)**, also known as a **Type 2 Lepra Reaction**, is a systemic immune-complex mediated (Type III hypersensitivity) reaction occurring primarily in lepromatous (LL) and borderline lepromatous (BL) leprosy. ### **Explanation of Options** * **A. Fever (Correct):** ENL is a multi-systemic inflammatory syndrome. **Fever** is the most common and characteristic constitutional symptom, often accompanied by malaise and prostration. It signifies the acute systemic nature of the immune response against released *M. leprae* antigens. * **B. Hepatitis:** While ENL can cause multi-organ involvement (like nephritis or orchitis), clinically significant hepatitis is not a standard or defining feature of the reaction. * **C. Joint Pain:** Although arthralgia can occur in ENL, "Fever" is considered the hallmark systemic sign in standard medical examinations. In many MCQ formats, if forced to choose the most definitive systemic feature, fever takes precedence. * **D. Skin Eruptions:** While ENL presents with painful, evanescent subcutaneous nodules, the term "skin eruptions" is too non-specific. The question specifically tests the recognition of the **systemic** inflammatory markers of the reaction. ### **Clinical Pearls for NEET-PG** * **Mechanism:** Type III Hypersensitivity (Immune-complex deposition). * **Classic Presentation:** Tender, erythematous, evanescent (short-lived) nodules appearing in crops, usually on the pretibial surface and face. * **Associated Features:** Neuritis, dactylitis, iridocyclitis, orchitis, and lymphadenopathy. * **Drug of Choice:** **Thalidomide** is the most effective treatment for ENL. Prednisolone and Clofazimine are also used. * **Trigger:** Often precipitated by starting Multi-Drug Therapy (MDT), pregnancy, or stress.

Q: An 8-year-old boy presents with a white, non-anesthetic, non-scaly hypopigmented macule on his face. What is the likely diagnosis?

Indeterminate leprosy. ### Explanation The correct diagnosis is **Indeterminate Leprosy**. This is the earliest clinical stage of leprosy, often seen in children. It typically presents as a single, poorly defined, hypopigmented macule, most commonly on the face, extensor surfaces, or buttocks. **Why Indeterminate Leprosy is correct:** In the early stages of leprosy, nerve damage is not yet extensive. Therefore, the classic signs of leprosy—such as **anesthesia** (loss of sensation) and **anhidrosis** (loss of sweating)—are frequently **absent**. The presence of a non-anesthetic, non-scaly hypopigmented macule in an endemic area should always raise suspicion for indeterminate leprosy. **Why the other options are incorrect:** * **Pityriasis alba:** While it also presents as hypopigmented macules on the face of children, it is characterized by **fine, powdery scaling** and is often associated with atopic dermatitis. * **Pityriasis versicolor:** This fungal infection presents with **fine scaling** (demonstrated by the "coup d'ongle" or scratch sign) and typically affects the trunk rather than the face in children. * **Neuritic leprosy:** This form involves nerve trunks without any visible skin lesions. It presents with motor weakness, sensory loss, or nerve thickening, but not with a hypopigmented macule. **NEET-PG High-Yield Pearls:** * **Indeterminate Leprosy:** Most cases (approx. 75%) self-heal; others evolve into the polar forms (TT or LL) depending on the patient's cell-mediated immunity. * **Histopathology:** Shows a non-specific perivascular and periappendageal lymphocytic infiltrate. Acid-fast bacilli (AFB) are rarely found. * **Clinical Tip:** If a hypopigmented patch on a child's face is **non-scaly** and **non-itchy**, think Indeterminate Leprosy first in the Indian context.

Q: Which of the following is true for multibacillary leprosy?

All of the above. **Explanation:** Leprosy (Hansen’s Disease) is classified by the WHO into **Paucibacillary (PB)** and **Multibacillary (MB)** types based on clinical and bacteriological criteria to simplify field treatment. 1. **Option A (Lesion Count):** According to the WHO classification, patients with **more than 5 skin lesions** are categorized as Multibacillary. Additionally, if a skin smear is positive at any site (regardless of the number of lesions), the case is classified as MB. 2. **Option B (Clofazimine):** The standard WHO Multi-Drug Therapy (MDT) for MB leprosy consists of three drugs: **Rifampicin, Dapsone, and Clofazimine**. Clofazimine is crucial as it provides both bactericidal action and anti-inflammatory properties, which help in preventing Type 2 Lepra reactions (ENL). 3. **Option C (Duration):** The recommended duration for MB-MDT is **12 months** (12 blister packs to be completed within 18 months). In contrast, PB leprosy is treated for 6 months. Since all three statements accurately describe the management and classification of Multibacillary leprosy, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **MDT Regimen (MB):** Rifampicin (600mg once monthly), Clofazimine (300mg once monthly + 50mg daily), and Dapsone (100mg daily). * **Cardinal Signs:** Hypopigmented/reddish patches with loss of sensation, thickened peripheral nerves, and positive skin smears. * **Drug Side Effects:** Clofazimine causes brownish-black skin discoloration; Dapsone can cause hemolysis or "Dapsone Syndrome." * **Accompanied PB Criteria:** 1–5 lesions and no nerve/single nerve involvement.

Tropical Dermatology Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following conditions is characterized by the sign of the groove?

A. Lymphogranuloma venereum (Correct Answer)
B. Granuloma inguinale
C. Syphilis
D. Chancroid

Explanation: **Explanation:** **Lymphogranuloma venereum (LGV)** is caused by the **L1, L2, and L3 serovars of *Chlamydia trachomatis***. The "Sign of the Groove" (Greenblatt’s sign) is a pathognomonic clinical finding in the secondary stage of LGV. It occurs when the inguinal and femoral lymph nodes enlarge simultaneously, separated by the rigid **inguinal ligament**. This creates a visible depression or "groove" between the two groups of inflamed lymph nodes. **Analysis of Incorrect Options:** * **B. Granuloma Inguinale (Donovanosis):** Caused by *Klebsiella granulomatis*. It presents with painless, beefy-red, velvety ulcers. It is characterized by "pseudobuboes" (subcutaneous granulation tissue) rather than true lymphadenopathy. * **C. Syphilis:** Primary syphilis presents with a painless, indurated "hard chancre." While it causes bilateral inguinal lymphadenopathy, the nodes are discrete, rubbery, and do not form a groove. * **D. Chancroid:** Caused by *Haemophilus ducreyi*. It presents with painful, soft ulcers and painful inflammatory buboes that are usually unilateral and may suppurate, but they do not form the characteristic groove sign. **High-Yield Clinical Pearls for NEET-PG:** * **Stages of LGV:** Primary (painless papule/ulcer), Secondary (Inguinal syndrome with the Groove sign), and Tertiary (Genito-anorectal syndrome/Elephantiasis). * **Diagnosis:** Frei test (historical), NAAT (current gold standard), and **Donovan bodies** (safety-pin appearance) are seen in Donovanosis, NOT LGV. * **Treatment:** Doxycycline (100 mg BID for 21 days) is the drug of choice for LGV.

Question 2: A young female presents with a history of fever and a nodular lesion over the shin. Histopathology reveals foamy histiocytes with neutrophilic infiltration. There is no evidence of vasculitis. What is the most probable diagnosis?

A. Sweet's Syndrome
B. Erythema nodosum (Correct Answer)
C. Erythema nodosum leprosum
D. Behcet's syndrome

Explanation: ### Explanation **Correct Answer: B. Erythema nodosum** **Why it is correct:** Erythema nodosum (EN) is the most common form of **septal panniculitis**. Clinically, it presents as tender, erythematous nodules typically located over the **pretibial area (shins)**, often accompanied by fever and malaise. Histopathologically, early lesions show edema and neutrophilic infiltration of the septa. As the lesion evolves, it is characterized by **Miescher’s radial granulomas**—small clusters of spindle-shaped or **foamy histiocytes** surrounding a central cleft. The absence of vasculitis is a hallmark feature that distinguishes EN from other forms of panniculitis. **Why the other options are incorrect:** * **A. Sweet’s Syndrome:** This is a neutrophilic dermatosis characterized by "juicy" erythematous plaques and high fever. Histology shows dense dermal neutrophilic infiltrate with papillary dermal edema, but it is not a primary panniculitis and does not typically present with foamy histiocytes in the septa. * **C. Erythema nodosum leprosum (ENL):** While ENL also presents with tender nodules and fever, it is a Type 2 Lepra reaction. Histologically, it is a **lobular panniculitis** and, crucially, it **must show evidence of vasculitis** (leukocytoclastic vasculitis) and the presence of *M. leprae* (AFB positive). * **D. Behcet’s syndrome:** While it can cause EN-like lesions, the systemic involvement (oral/genital ulcers, uveitis) and the characteristic histopathology (often showing vasculitis) do not fit the isolated description provided. **NEET-PG High-Yield Pearls:** * **Most common cause of EN:** Idiopathic (followed by Streptococcal infections, Sarcoidosis, and TB). * **Histopathology Key:** Septal panniculitis **without** vasculitis = Erythema Nodosum. * **Löfgren Syndrome:** Triad of EN, bilateral hilar lymphadenopathy, and arthritis (highly suggestive of Sarcoidosis). * **Miescher’s Radial Granulomas:** Pathognomonic histological finding for EN.

Question 3: A young tourist presents with an erythematous lesion on the cheek with central crusting after visiting a region endemic for a specific protozoal infection. What is the likely dermatological condition?

A. Cutaneous Leishmaniasis (Correct Answer)
B. Systemic Lupus Erythematosus
C. Lupus vulgaris
D. Chilblains

Explanation: ### Explanation **Correct Option: A. Cutaneous Leishmaniasis** Cutaneous Leishmaniasis (CL), often referred to as "Oriental Sore" or "Delhi Boil," is caused by the protozoan *Leishmania* species and transmitted by the bite of an infected **female sandfly (*Phlebotomus*)**. The classic presentation begins as a small erythematous papule at the inoculation site (usually exposed areas like the face), which evolves into a nodule and eventually develops **central crusting** or ulceration with a raised, indurated border. The history of travel to an endemic region is a crucial diagnostic clue. **Why Incorrect Options are Wrong:** * **B. Systemic Lupus Erythematosus (SLE):** Typically presents with a "malar rash" (butterfly distribution) that spares the nasolabial folds. It is an autoimmune condition, not associated with travel to protozoal endemic areas or central crusting. * **C. Lupus Vulgaris:** This is a chronic form of cutaneous tuberculosis. While it affects the face, it typically presents as "apple-jelly" nodules on diascopy and follows a very chronic, progressive course rather than an acute post-travel presentation. * **D. Chilblains (Pernio):** An inflammatory response to cold, damp conditions. It presents as itchy, purple-red bumps on fingers or toes, not as a crusted facial lesion following tropical travel. **High-Yield Clinical Pearls for NEET-PG:** * **Vector:** Female Sandfly (*Phlebotomus*). * **Diagnosis:** Skin biopsy or slit-skin smear showing **LD bodies** (Leishman-Donovan bodies) within macrophages. * **Treatment of Choice:** Intralesional or systemic **Sodium Stibogluconate** (Pentavalent antimonials) or Miltefosine. * **Volcano Sign:** The appearance of a crusted ulcer with a central pit is often described as the "volcano sign."

Question 4: What is characteristic of donovanosis?

A. Pseudolymphadenopathy (Correct Answer)
B. Penicillin is used for treatment
C. Painful ulcer
D. Suppurative lymphadenopathy

Explanation: **Donovanosis (Granuloma Inguinale)** is a chronic, progressive bacterial infection caused by the intracellular Gram-negative organism *Klebsiella granulomatis*. ### **Explanation of the Correct Answer** **A. Pseudolymphadenopathy:** This is the hallmark of Donovanosis. Unlike other STIs, the infection does not typically involve the regional lymph nodes. Instead, the subcutaneous granulation tissue spreads along the inguinal folds, causing firm, non-tender swellings that mimic enlarged lymph nodes. These are called **"pseudobuboes."** ### **Why Other Options are Incorrect** * **B. Penicillin is used for treatment:** Penicillin is ineffective. The CDC-recommended first-line treatment is **Azithromycin** (1g weekly or 500mg daily for at least 3 weeks). * **C. Painful ulcer:** Donovanosis is classically **painless**. It presents as beefy-red, friable (bleeds easily on touch) ulcers with rolled-out edges. Pain only occurs if there is secondary bacterial superinfection. * **D. Suppurative lymphadenopathy:** This is characteristic of **Lymphogranuloma Venereum (LGV)** or **Chancroid**, where true fluctuant buboes form. Donovanosis lacks true lymph node involvement. ### **High-Yield Clinical Pearls for NEET-PG** * **Donovan Bodies:** Diagnosis is confirmed by seeing "safety-pin" appearing organisms within large macrophages on a Giemsa or Wright stain (crush smear). * **Clinical Appearance:** Often described as "beefy-red" granulation tissue with a "velvety" texture. * **Extragenital Involvement:** Can occur in the mouth, liver, or bone via autoinoculation or hematogenous spread. * **Mnemonic:** Remember the **"4 Ps"** of Donovanosis: **P**ainless, **P**rogressive, **P**seudobuboes, and **P**olymorphic (various clinical types like ulcerogranulomatous, hypertrophic, etc.).

Question 5: What is the treatment for Lucio phenomenon?

A. Steroids
B. Lenalidomide
C. Clofazimine
D. Exchange transfusion (Correct Answer)

Explanation: **Explanation:** **Lucio Phenomenon** is a rare, life-threatening variant of Type 2 Lepra Reaction (ENL) seen exclusively in patients with diffuse lepromatous leprosy (Lucio leprosy). It is characterized by necrotizing vasculitis of small vessels, leading to extensive, jagged, purpuric macules and large areas of skin necrosis. 1. **Why Exchange Transfusion is Correct:** The pathogenesis involves severe hypercoagulability, immune complex deposition, and massive bacterial load leading to vascular occlusion. **Exchange transfusion** (or plasmapheresis) is considered the treatment of choice in severe, life-threatening cases because it rapidly removes circulating immune complexes, inflammatory cytokines, and helps correct the underlying coagulopathy. 2. **Why Other Options are Incorrect:** * **Steroids (A):** While used in standard ENL, they are often insufficient as monotherapy for Lucio phenomenon due to the primary mechanism being thrombotic infarct rather than simple inflammation. * **Lenalidomide (B):** This is a derivative of Thalidomide. While Thalidomide is the drug of choice for standard ENL, it is notably **ineffective** in Lucio phenomenon. * **Clofazimine (C):** It has anti-inflammatory properties used in chronic ENL but acts too slowly to manage the acute, necrotic crisis of Lucio phenomenon. **Clinical Pearls for NEET-PG:** * **Geographic association:** Most common in Mexico and Central America. * **Clinical hallmark:** "Median-sized" necrotic ulcers with a jagged border. * **Histopathology:** Shows colonization of endothelial cells by *M. lepromatosis* or *M. leprae*, resulting in endothelial proliferation and thrombosis. * **Key distinction:** Unlike ENL, Lucio phenomenon typically lacks systemic symptoms like high fever in the early stages, focusing instead on cutaneous infarcts.

Question 6: A child from Bihar presents with hypopigmented patches on the face. What is the most likely diagnosis?

A. Pityriasis alba
B. Leprosy (Correct Answer)
C. Vitiligo
D. None of the above

Explanation: **Explanation:** In the context of NEET-PG, the geographical location provided in a clinical stem is a critical diagnostic clue. **Bihar** is a highly endemic region for **Leprosy (Hansen’s Disease)** in India. In an endemic area, any hypopigmented patch in a child should be considered Leprosy until proven otherwise. The diagnosis is clinically supported by the presence of sensory loss (anesthesia/hypoesthesia) within the patch and/or thickened peripheral nerves. **Analysis of Options:** * **Leprosy (Correct):** The most common presentation in children is a solitary, ill-defined hypopigmented patch (Tuberculoid or Indeterminate spectrum). The epidemiological link to Bihar makes this the most likely diagnosis for exam purposes. * **Pityriasis alba:** This also presents as hypopigmented patches on the face of children, often associated with atopy. However, the patches usually have fine scaling and lack the sensory loss or nerve involvement characteristic of Leprosy. * **Vitiligo:** This presents as "depigmented" (chalky white) macules rather than "hypopigmented" patches. The borders are usually well-defined, and sensation remains intact. **Clinical Pearls for NEET-PG:** * **Cardinal Signs of Leprosy:** 1. Hypopigmented/erythematous patches with definite loss of sensation. 2. Thickened/tender peripheral nerves. 3. Positive skin smear for Acid Fast Bacilli (*M. leprae*). * **Differential Diagnosis:** For a hypopigmented patch on the face, always consider *Pityriasis versicolor* (fungal, "spaghetti and meatballs" appearance on KOH) and *Post-inflammatory hypopigmentation*. * **High-Yield Fact:** The most common nerve involved in Leprosy is the **Ulnar nerve**, but the most common nerve involved in the face is the **Zygomatic branch of the Facial nerve** (leading to lagophthalmos).

Question 7: What is the early reaction of the Lepromin test known as?

A. Late Mitsuda reaction
B. Fernandez reaction (Correct Answer)
C. Early Mitsuda reaction
D. First lepromin reaction

Explanation: The **Lepromin test** is a skin test used to measure the cell-mediated immunity (CMI) of a patient against *Mycobacterium leprae*. It is not a diagnostic test for leprosy but is used for classification and prognosis. ### Explanation of the Correct Answer The **Fernandez reaction** is the **early reaction** observed in the Lepromin test. It occurs **48 to 72 hours** after the intradermal injection of lepromin. It is a Type IV (delayed-type) hypersensitivity reaction to the soluble bacterial proteins. A positive Fernandez reaction indicates that the individual has been previously sensitized to *M. leprae* antigens. ### Why Other Options are Incorrect * **Late Mitsuda reaction (Option A):** This is the **late reaction** observed **3 to 4 weeks** after the injection. It represents a granulomatous response to the bacillary components of the lepromin. It is highly positive in Tuberculoid leprosy (TT) and negative in Lepromatous leprosy (LL). * **Early Mitsuda reaction (Option C):** This is a misnomer. The Mitsuda reaction is inherently a late-phase reaction. * **First lepromin reaction (Option D):** This is not a standard medical term used to describe the phases of the Lepromin test. ### High-Yield Clinical Pearls for NEET-PG * **Prognostic Value:** A positive Mitsuda reaction indicates strong CMI and a better prognosis (Tuberculoid end of the spectrum). * **Classification:** Lepromin test is **Negative** in Lepromatous Leprosy (LL) due to anergy and **Positive** in Tuberculoid Leprosy (TT). * **Antigen Types:** * *Lepromin H (Hayashi):* Derived from human leproma. * *Lepromin A (Armadillo):* Derived from armadillo-grown bacilli (more commonly used today). * **Memory Aid:** **F**ernandez = **F**ast (48-72 hours); **M**itsuda = **M**onth (approx. 3-4 weeks).

Question 8: Which of the following are clinical features of Erythema nodosum leprosum?

A. Fever (Correct Answer)
B. Hepatitis
C. Joint pain
D. Skin eruptions

Explanation: **Erythema Nodosum Leprosum (ENL)**, also known as a **Type 2 Lepra Reaction**, is a systemic immune-complex mediated (Type III hypersensitivity) reaction occurring primarily in lepromatous (LL) and borderline lepromatous (BL) leprosy. ### **Explanation of Options** * **A. Fever (Correct):** ENL is a multi-systemic inflammatory syndrome. **Fever** is the most common and characteristic constitutional symptom, often accompanied by malaise and prostration. It signifies the acute systemic nature of the immune response against released *M. leprae* antigens. * **B. Hepatitis:** While ENL can cause multi-organ involvement (like nephritis or orchitis), clinically significant hepatitis is not a standard or defining feature of the reaction. * **C. Joint Pain:** Although arthralgia can occur in ENL, "Fever" is considered the hallmark systemic sign in standard medical examinations. In many MCQ formats, if forced to choose the most definitive systemic feature, fever takes precedence. * **D. Skin Eruptions:** While ENL presents with painful, evanescent subcutaneous nodules, the term "skin eruptions" is too non-specific. The question specifically tests the recognition of the **systemic** inflammatory markers of the reaction. ### **Clinical Pearls for NEET-PG** * **Mechanism:** Type III Hypersensitivity (Immune-complex deposition). * **Classic Presentation:** Tender, erythematous, evanescent (short-lived) nodules appearing in crops, usually on the pretibial surface and face. * **Associated Features:** Neuritis, dactylitis, iridocyclitis, orchitis, and lymphadenopathy. * **Drug of Choice:** **Thalidomide** is the most effective treatment for ENL. Prednisolone and Clofazimine are also used. * **Trigger:** Often precipitated by starting Multi-Drug Therapy (MDT), pregnancy, or stress.

Question 9: An 8-year-old boy presents with a white, non-anesthetic, non-scaly hypopigmented macule on his face. What is the likely diagnosis?

A. Pityriasis alba
B. Pityriasis versicolor
C. Indeterminate leprosy (Correct Answer)
D. Neuritic leprosy

Explanation: ### Explanation The correct diagnosis is **Indeterminate Leprosy**. This is the earliest clinical stage of leprosy, often seen in children. It typically presents as a single, poorly defined, hypopigmented macule, most commonly on the face, extensor surfaces, or buttocks. **Why Indeterminate Leprosy is correct:** In the early stages of leprosy, nerve damage is not yet extensive. Therefore, the classic signs of leprosy—such as **anesthesia** (loss of sensation) and **anhidrosis** (loss of sweating)—are frequently **absent**. The presence of a non-anesthetic, non-scaly hypopigmented macule in an endemic area should always raise suspicion for indeterminate leprosy. **Why the other options are incorrect:** * **Pityriasis alba:** While it also presents as hypopigmented macules on the face of children, it is characterized by **fine, powdery scaling** and is often associated with atopic dermatitis. * **Pityriasis versicolor:** This fungal infection presents with **fine scaling** (demonstrated by the "coup d'ongle" or scratch sign) and typically affects the trunk rather than the face in children. * **Neuritic leprosy:** This form involves nerve trunks without any visible skin lesions. It presents with motor weakness, sensory loss, or nerve thickening, but not with a hypopigmented macule. **NEET-PG High-Yield Pearls:** * **Indeterminate Leprosy:** Most cases (approx. 75%) self-heal; others evolve into the polar forms (TT or LL) depending on the patient's cell-mediated immunity. * **Histopathology:** Shows a non-specific perivascular and periappendageal lymphocytic infiltrate. Acid-fast bacilli (AFB) are rarely found. * **Clinical Tip:** If a hypopigmented patch on a child's face is **non-scaly** and **non-itchy**, think Indeterminate Leprosy first in the Indian context.

Question 10: Which of the following is true for multibacillary leprosy?

A. More than 5 lesions on skin smears
B. Clofazimine is an important drug to be given
C. Treatment is to be given for 12 months
D. All of the above (Correct Answer)

Explanation: **Explanation:** Leprosy (Hansen’s Disease) is classified by the WHO into **Paucibacillary (PB)** and **Multibacillary (MB)** types based on clinical and bacteriological criteria to simplify field treatment. 1. **Option A (Lesion Count):** According to the WHO classification, patients with **more than 5 skin lesions** are categorized as Multibacillary. Additionally, if a skin smear is positive at any site (regardless of the number of lesions), the case is classified as MB. 2. **Option B (Clofazimine):** The standard WHO Multi-Drug Therapy (MDT) for MB leprosy consists of three drugs: **Rifampicin, Dapsone, and Clofazimine**. Clofazimine is crucial as it provides both bactericidal action and anti-inflammatory properties, which help in preventing Type 2 Lepra reactions (ENL). 3. **Option C (Duration):** The recommended duration for MB-MDT is **12 months** (12 blister packs to be completed within 18 months). In contrast, PB leprosy is treated for 6 months. Since all three statements accurately describe the management and classification of Multibacillary leprosy, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **MDT Regimen (MB):** Rifampicin (600mg once monthly), Clofazimine (300mg once monthly + 50mg daily), and Dapsone (100mg daily). * **Cardinal Signs:** Hypopigmented/reddish patches with loss of sensation, thickened peripheral nerves, and positive skin smears. * **Drug Side Effects:** Clofazimine causes brownish-black skin discoloration; Dapsone can cause hemolysis or "Dapsone Syndrome." * **Accompanied PB Criteria:** 1–5 lesions and no nerve/single nerve involvement.

Question 11: What is the drug of choice for Granuloma venereum?

A. Sulfonamides
B. Streptomycin
C. Penicillin
D. Erythromycin (Correct Answer)

Explanation: **Explanation:** **Granuloma venereum**, also known as **Donovanosis**, is a chronic, progressive bacterial infection of the genital and perianal regions caused by the Gram-negative intracellular organism *Klebsiella granulomatis* (formerly *Calymmatobacterium granulomatis*). **Why Erythromycin is the Correct Answer:** According to standard dermatological guidelines and traditional textbooks (like IADVL), **Erythromycin** (500 mg four times daily) is considered a primary drug of choice, particularly in pregnancy. However, it is important to note that modern CDC guidelines now recommend **Azithromycin** (1g weekly or 500mg daily) as the first-line treatment due to better compliance. In the context of this specific MCQ, Erythromycin remains the most appropriate choice among the provided options. **Why Other Options are Incorrect:** * **Sulfonamides:** These were used historically but are no longer preferred due to high rates of bacterial resistance and lower efficacy compared to macrolides. * **Streptomycin:** While effective, it requires intramuscular administration and carries risks of ototoxicity and nephrotoxicity, making it a second or third-line alternative. * **Penicillin:** *Klebsiella granulomatis* is inherently resistant to Penicillin; it is the drug of choice for Syphilis, not Donovanosis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Donovan Bodies:** Pathognomonic finding; these are safety-pin shaped organisms seen within large vacuolated macrophages on a **crush smear** (Giemsa or Wright stain). 2. **Clinical Presentation:** Characterized by **painless, beefy-red, velvety ulcers** that bleed easily on touch (friable). 3. **Pseudobubo:** It does not cause true lymphadenopathy; instead, it causes "pseudobuboes," which are subcutaneous granulomatous swellings in the inguinal region. 4. **Treatment Duration:** Therapy must be continued for at least 3 weeks or until all lesions have completely epithelialized.

Question 12: Which of the following is least likely to be a mode of transmission of Hansen's disease?

A. Mosquito bite
B. Droplet infection
C. Transplacental (Correct Answer)
D. Breast milk

Explanation: **Explanation:** Hansen’s disease (Leprosy), caused by *Mycobacterium leprae*, primarily spreads through prolonged, close contact with untreated multibacillary patients. **1. Why Transplacental is the Correct Answer:** While *M. leprae* has been detected in the placenta and umbilical cord blood of infected mothers, **congenital transmission (transplacental) is extremely rare and considered the least likely mode of transmission.** Most children born to mothers with leprosy are born healthy. The risk to the infant primarily arises from post-natal exposure to the mother’s respiratory droplets or skin contact rather than intrauterine infection. **2. Analysis of Other Options:** * **Droplet Infection (Option B):** This is the **most common and primary route** of transmission. Large numbers of bacilli are shed from the nasal mucosa of untreated lepromatous patients during sneezing or coughing. * **Breast Milk (Option D):** *M. leprae* has been demonstrated in the breast milk of lactating mothers with lepromatous leprosy. While not the primary route, it is a documented potential vehicle for transmission. * **Mosquito Bite (Option A):** Arthropod vectors (mosquitos, bedbugs, and flies) have been shown to carry *M. leprae* mechanically. While their epidemiological significance is debated, they are recognized as a possible minor mode of transmission in endemic areas. **Clinical Pearls for NEET-PG:** * **Incubation Period:** Longest among bacterial infections (Average: 3–5 years). * **Primary Site of Entry:** Respiratory tract (nasal mucosa) is the most accepted portal of entry. * **Armadillos:** Known natural non-human reservoirs of *M. leprae*. * **Cooler Temperatures:** The organism prefers temperatures of 27–30°C, explaining its predilection for peripheral nerves, skin, and the anterior chamber of the eye.

Question 13: A 48-year-old male presents with a three-month history of non-itchy, generalized papulo-nodular lesions. Physical examination reveals no other abnormalities. Slit smear from a nodule is negative for acid-fast bacilli (AFB). Blood VDRL is reactive at a 1:2 dilution. What is the most likely diagnosis?

A. Drug eruption
B. Lepromatous leprosy
C. Post kala azar dermal leishmaniasis
D. Secondary syphilis (Correct Answer)

Explanation: **Explanation:** The clinical presentation of generalized, non-itchy papulo-nodular lesions in an adult, combined with a reactive VDRL, is classic for **Secondary Syphilis**. Known as the "Great Imitator," secondary syphilis typically presents with a polymorphic rash (macular, papular, or nodular) that characteristically involves the palms and soles. A VDRL titer of 1:2, while low, is significant in the context of suggestive clinical lesions. **Why the other options are incorrect:** * **Lepromatous Leprosy:** While it presents with generalized nodules, the **negative slit skin smear (SSS)** for Acid-Fast Bacilli (AFB) effectively rules this out, as lepromatous leprosy (multibacillary) would show a high bacterial index. * **Post Kala-Azar Dermal Leishmaniasis (PKDL):** This typically presents with hypopigmented macules, malar erythema, or nodules following an episode of Visceral Leishmaniasis. It would not cause a reactive VDRL. * **Drug Eruption:** These are usually acute in onset, often pruritic (itchy), and temporally related to drug intake. They do not explain the reactive syphilis serology. **High-Yield Clinical Pearls for NEET-PG:** * **Secondary Syphilis:** Always look for involvement of palms and soles, generalized lymphadenopathy (epitrochlear), and "moth-eaten" alopecia. * **Prozone Phenomenon:** In secondary syphilis, very high antibody titers can sometimes cause a false-negative VDRL result; the serum must be diluted to get a positive result. * **VDRL vs. TPHA:** VDRL is a non-specific screening test (titer reflects disease activity), while TPHA/FTA-ABS are specific treponemal tests that remain positive for life.

Question 14: Erythema nodosum leprosum is seen in a 16-year-old boy. This is a feature of which of the following types of leprosy?

A. Lepromatous (Correct Answer)
B. Borderline
C. Tuberculoid
D. Borderline tuberculoid

Explanation: **Explanation:** **Erythema Nodosum Leprosum (ENL)**, also known as a **Type 2 Lepra Reaction**, is a classic example of a **Type III hypersensitivity reaction** (immune-complex mediated). It occurs due to the deposition of antigen-antibody complexes in tissues, leading to systemic inflammation. 1. **Why Lepromatous (Option A) is correct:** ENL occurs almost exclusively in patients with a high bacterial load (multibacillary) and high humoral (antibody) response. It is most commonly seen in **Lepromatous Leprosy (LL)** and sometimes in **Borderline Lepromatous (BL)** leprosy. It is triggered by the rapid killing of *M. leprae* (often after starting MDT), which releases large amounts of fragmented bacterial antigens into the bloodstream. 2. **Why other options are incorrect:** * **Tuberculoid (TT) and Borderline Tuberculoid (BT):** These are paucibacillary forms with high cell-mediated immunity (CMI) and very low bacterial load. Type 2 reactions (ENL) do not occur here; instead, these patients are prone to **Type 1 Lepra Reactions** (Delayed Hypersensitivity). * **Borderline (BB):** While borderline cases can shift, ENL is specifically associated with the "lepromatous end" of the spectrum where the bacillary index is high. **Clinical Pearls for NEET-PG:** * **Clinical Features:** Characterized by sudden onset of tender, evanescent, erythematous nodules, high-grade fever, malaise, and systemic involvement (neuritis, orchitis, iridocyclitis, and glomerulonephritis). * **Drug of Choice:** **Thalidomide** is the most effective treatment for ENL. Systemic corticosteroids and Clofazimine are also used. * **Timing:** Unlike Type 1 reactions (which occur early), ENL typically occurs later in the course of treatment.

Question 15: Which of the following statements about mycetoma is false?

A. It can affect the lower and upper extremities.
B. It is caused by actinomycetes and filamentous fungi.
C. Diagnosis is made by examining pus.
D. It is uncommon in India. (Correct Answer)

Explanation: ### **Explanation: Mycetoma** **1. Why Option D is the Correct Answer (False Statement):** Mycetoma is **not uncommon** in India. In fact, India is part of the global "Mycetoma Belt" (along with Sudan, Mexico, and Venezuela). It is an endemic chronic granulomatous infection frequently seen in the tropical and subtropical regions of India, particularly among rural laborers and farmers in states like Rajasthan, Tamil Nadu, and West Bengal. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** While the foot is the most common site (Madura foot), mycetoma can affect any part of the body exposed to soil, including the **lower extremities, upper extremities (hands/shoulders), and the back**. * **Option B:** Mycetoma is classified into two types based on the causative agent: **Actinomycetoma** (caused by filamentous bacteria like *Nocardia* and *Actinomadura*) and **Eumycetoma** (caused by true fungi like *Madurella mycetomatis*). * **Option C:** Diagnosis is primarily clinical, characterized by the **triad of tumefaction (swelling), draining sinuses, and the presence of grains**. Examining the pus or discharge for these characteristic grains (color, size, and consistency) is a crucial diagnostic step. **3. High-Yield Clinical Pearls for NEET-PG:** * **The Triad:** Localized swelling + Multiple discharging sinuses + Grains. * **Grains as Clues:** * **Yellow/White grains:** Usually Actinomycetoma (e.g., *Nocardia*). * **Black grains:** Usually Eumycetoma (e.g., *Madurella*). * **Red grains:** Pathognomonic for *Actinomadura pelletieri*. * **Radiology:** The **"Dot-in-circle" sign** on MRI is a highly specific diagnostic feature. * **Treatment:** Actinomycetoma responds well to antibiotics (e.g., **Welsh Regime**: Amikacin + Cotrimoxazole), whereas Eumycetoma requires long-term antifungals (Itraconazole) and often surgical debridement.

Question 16: A 27-year-old patient was diagnosed to have borderline leprosy and started on multidrug therapy for multibacillary leprosy. Six weeks later, he developed pain in the nerves and redness and swelling of the skin lesions. The management of his illness should include all of the following, except?

A. Stop anti-leprosy drugs (Correct Answer)
B. Systemic corticosteroids
C. Rest to the affected limbs
D. Analgesics

Explanation: ### **Explanation** The clinical presentation describes a **Type 1 Lepra Reaction (Reversal Reaction)**. This is a delayed hypersensitivity (Type IV) reaction occurring in borderline cases (BT, BB, BL) due to an increase in cell-mediated immunity. It typically presents with acute inflammation of existing skin lesions (erythema, edema) and neuritis (nerve pain and tenderness). #### **Why "Stop anti-leprosy drugs" is the Correct Answer (The "Except" Option):** In both Type 1 and Type 2 lepra reactions, **Multidrug Therapy (MDT) must never be stopped.** The reaction is an immunological phenomenon, not a drug allergy or a sign of treatment failure. Stopping MDT would allow the *M. leprae* bacilli to multiply, potentially worsening the patient's long-term prognosis and increasing the risk of drug resistance. #### **Why the Other Options are Incorrect (Standard Management):** * **Systemic Corticosteroids (Option B):** These are the **drug of choice** for Type 1 reactions, especially when there is nerve involvement (neuritis). They suppress the exaggerated immune response and prevent permanent nerve damage. * **Rest to the affected limbs (Option C):** Splinting or resting the limb involved by an inflamed nerve is essential to prevent further mechanical trauma and permanent paralysis. * **Analgesics (Option D):** Used as supportive therapy to manage the acute pain associated with neuritis and skin inflammation. --- ### **NEET-PG High-Yield Pearls** * **Type 1 Reaction:** Seen in Borderline leprosy; characterized by "upgrading" (moving toward TT) or "downgrading" (moving toward LL) of immunity. * **Type 2 Reaction (ENL):** A Type III hypersensitivity (immune-complex mediated) seen in BL and LL. Presents with tender evanescent nodules, fever, and systemic features. * **Drug of Choice for Type 2:** Thalidomide (if not contraindicated) or high-dose steroids. * **Golden Rule:** **Never stop MDT during any lepra reaction.**

Question 17: In Hansen's disease, which nerve is commonly affected at the elbow?

A. Ulnar nerve (Correct Answer)
B. Median nerve
C. Radial nerve
D. Musculocutaneous nerve

Explanation: **Explanation:** **Hansen’s Disease (Leprosy)** is a chronic infectious disease caused by *Mycobacterium leprae*, which has a unique predilection for peripheral nerves. The bacteria prefer cooler temperatures, which is why they primarily affect superficial nerve trunks located near the skin surface. **Why the Ulnar Nerve is Correct:** The **ulnar nerve** is the most commonly affected peripheral nerve in leprosy. At the elbow, it passes through the **cubital tunnel** (behind the medial epicondyle), where it is superficial and subject to lower temperatures. This environment facilitates the proliferation of *M. leprae*, leading to nerve thickening (neuritis) and subsequent motor/sensory loss. Involvement here typically results in a "Claw Hand" deformity (specifically the ring and little fingers). **Analysis of Incorrect Options:** * **Median Nerve:** While frequently involved in leprosy, it is typically affected at the **wrist** (within the carpal tunnel), not the elbow. Its involvement leads to "Ape Thumb" deformity. * **Radial Nerve:** This nerve is less commonly affected than the ulnar or median nerves. When involved, it usually occurs in the **radial groove** of the humerus, leading to "Wrist Drop." * **Musculocutaneous Nerve:** This nerve is rarely involved in leprosy as it is deeply situated within the musculature of the arm. **High-Yield Clinical Pearls for NEET-PG:** * **Most common nerve involved in Leprosy:** Ulnar nerve. * **Most common nerve involved in the Lower Limb:** Common Peroneal Nerve (leads to Foot Drop). * **Nerve thickening:** Always palpate the nerve proximal to the site of entrapment (e.g., palpate the ulnar nerve just above the medial epicondyle). * **Facial Nerve:** The most common cranial nerve involved, leading to Lagophthalmos. * **Great Auricular Nerve:** Often visibly thickened in the neck; it is a purely sensory nerve.

Question 18: Which of the following are clinical features of lepromatous leprosy?

A. Leonine facies
B. Loss of libido and impotence
C. Saddle nose
D. All the above (Correct Answer)

Explanation: In Lepromatous Leprosy (LL), the cell-mediated immunity (CMI) is severely depressed, leading to uncontrolled multiplication of *Mycobacterium leprae* and widespread systemic involvement. **Explanation of Clinical Features:** * **Leonine Facies:** This is a hallmark of advanced LL. It results from diffuse infiltration of the facial skin by lepromas, leading to thickening of the forehead, prominence of the supraorbital ridges, and pendulous earlobes, giving the patient a "lion-like" appearance. * **Loss of Libido and Impotence:** Unlike Tuberculoid leprosy, LL involves internal organs. The bacilli directly invade the testes (orchitis), leading to testicular atrophy. This results in primary hypogonadism, causing loss of libido, impotence, and gynecomastia. * **Saddle Nose:** The bacilli frequently involve the nasal mucosa and the cartilaginous septum. Chronic inflammation leads to perforation of the nasal septum and collapse of the nasal bridge, resulting in the characteristic "saddle nose" deformity. **Why "All the above" is correct:** Since LL is a multi-systemic disease characterized by high bacillary load (multibacillary), it manifests through cutaneous infiltration (Leonine facies), mucosal destruction (Saddle nose), and endocrine dysfunction (Impotence). **High-Yield Clinical Pearls for NEET-PG:** * **Madarosis:** Loss of the lateral one-third of the eyebrows is a classic early sign of LL. * **Glove and Stocking Anesthesia:** LL presents with symmetrical sensory loss in the distal extremities. * **Bacteriological Index (BI):** In LL, the BI is typically high (4+ to 6+). * **Lepromin Test:** Always **negative** in Lepromatous Leprosy due to the absence of CMI. * **Histopathology:** Shows a "Grenz Zone" (a subepidermal clear zone) and Virchow cells (foamy macrophages).

Question 19: A patient with leprosy presents with clumsiness of the hand due to ulnar nerve involvement. Palsy of which muscle group would cause this clumsiness?

A. Extensor carpi ulnaris
B. Abductor pollicis brevis
C. Opponens pollicis
D. Interosseous muscles (Correct Answer)

Explanation: **Explanation:** In leprosy (Hansen’s disease), the **ulnar nerve** is the most commonly involved peripheral nerve. Clumsiness of the hand in ulnar nerve palsy is primarily due to the paralysis of the **interosseous muscles** (both dorsal and palmar) and the **medial two lumbricals**. These muscles are responsible for the fine, coordinated movements of the fingers. Loss of the interossei leads to a loss of finger abduction/adduction and a weakened "precision grip," resulting in the characteristic clumsiness. **Analysis of Options:** * **Interosseous muscles (Correct):** Supplied by the deep branch of the ulnar nerve. Their paralysis leads to "guttering" (atrophy of intermetacarpal spaces) and loss of fine motor control. * **Extensor carpi ulnaris (Incorrect):** This muscle is supplied by the **posterior interosseous nerve** (a branch of the radial nerve). Its involvement would affect wrist extension and ulnar deviation, not intrinsic hand coordination. * **Abductor pollicis brevis & Opponens pollicis (Incorrect):** These are muscles of the thenar eminence, which are supplied by the **median nerve**. Their involvement would lead to "Ape thumb deformity" rather than ulnar-related clumsiness. **High-Yield Clinical Pearls for NEET-PG:** * **Ulnar Claw Hand:** Characterized by hyperextension at the MCP joints and flexion at the IP joints of the 4th and 5th digits. * **Froment’s Sign:** A positive test indicates ulnar nerve palsy due to paralysis of the **Adductor pollicis** (the patient flexes the thumb IP joint using the median nerve-supplied FPL to grip paper). * **Nerve Thickening:** In leprosy, the ulnar nerve is typically palpated just above the medial epicondyle of the humerus. * **Ulnar Paradox:** A high ulnar nerve lesion (at the elbow) results in a *less* prominent clawing than a low lesion (at the wrist) because the medial half of the FDP is also paralyzed.

Question 20: A 20-year-old male from Jaipur presents with an erythematous lesion on his cheek with central crusting. What is the likely diagnosis?

A. Systemic Lupus Erythematosus (SLE)
B. Lupus Vulgaris
C. Chilblain
D. Cutaneous Leishmaniasis (Correct Answer)

Explanation: ### **Explanation** **Correct Answer: D. Cutaneous Leishmaniasis** **Medical Concept:** The diagnosis is based on the classic clinical presentation and geographical context. Jaipur (Rajasthan) is a known endemic belt for **Cutaneous Leishmaniasis (CL)** in India, caused primarily by *Leishmania tropica*. The typical lesion starts as a papule that evolves into a "volcano-like" ulcer or an erythematous plaque with **central crusting** (often called the "Oriental Sore"). The presence of a chronic, painless, crusted lesion on exposed areas like the cheek in a young patient from an endemic zone is highly suggestive of CL. **Why other options are incorrect:** * **A. Systemic Lupus Erythematosus (SLE):** While SLE presents with a malar rash, it is typically a transient or persistent photosensitive erythema (butterfly distribution) without central crusting or ulceration. * **B. Lupus Vulgaris:** This is a form of cutaneous tuberculosis. It typically presents as "apple-jelly" nodules on diascopy and progresses slowly with peripheral expansion and central scarring, rather than acute crusting. * **C. Chilblain:** These are localized inflammatory lesions (perniosis) resulting from exposure to cold. They usually occur on acral areas (fingers/toes) and are unlikely to present as a solitary crusted cheek lesion in the climate of Jaipur. **NEET-PG High-Yield Pearls:** * **Vector:** Sandfly (*Phlebotomus papatasi*). * **Diagnosis:** Skin smear (Giemsa stain) shows **LD bodies** (Amastigote form) within macrophages. * **Leishmanin (Montenegro) Test:** Positive in Cutaneous Leishmaniasis but **negative** in Visceral Leishmaniasis (Kala-azar). * **Treatment of Choice:** Sodium Stibogluconate (Pentavalent antimonials) or Miltefosine. * **Key Sign:** "Volcano sign" (ulcer with raised dusky red borders).

Question 21: Which of the following is characteristic of donovanosis?

A. Pseudolymphadenopathy (Correct Answer)
B. Penicillin is used for treatment
C. Painful ulcer
D. Suppurative lymphadenopathy

Explanation: **Donovanosis (Granuloma Inguinale)** is a chronic, progressive bacterial infection caused by the intracellular Gram-negative organism *Klebsiella granulomatis*. ### **Explanation of Options** * **A. Pseudolymphadenopathy (Correct):** This is the hallmark of donovanosis. Unlike other STIs, the infection does not involve the regional lymph nodes. Instead, it causes subcutaneous granulation tissue to build up in the inguinal region, creating a bulge that mimics a bubo. This is termed a **"pseudobubo."** * **B. Penicillin is used for treatment:** Penicillin is ineffective. The WHO and CDC recommend **Azithromycin** (1g weekly or 500mg daily) for at least 3 weeks or until lesions have completely healed. * **C. Painful ulcer:** Donovanosis is classically characterized by **painless**, beefy-red, friable (bleeds easily on touch) ulcers with rolled-out edges. Pain only occurs if there is secondary bacterial infection. * **D. Suppurative lymphadenopathy:** This is characteristic of *Lymphogranuloma Venereum (LGV)* or *Chancroid*. In Donovanosis, there is no true lymphadenopathy. ### **High-Yield Clinical Pearls for NEET-PG** * **Causative Agent:** *Klebsiella granulomatis* (formerly *Calymmatobacterium granulomatis*). * **Diagnosis:** Identification of **Donovan Bodies** (safety-pin appearance) within large mononuclear cells (macrophages) on a Giemsa or Wright stain of a tissue smear. * **Clinical Appearance:** "Beefy red" granulation tissue; highly vascular; often described as "serpiginous" ulcers. * **Key Differentiator:** It is one of the few causes of **painless** genital ulcers (alongside primary Syphilis), but unlike Syphilis, the base is highly vascular and bleeds easily.

Question 22: Veldt sore is most common in which of the following conditions or environments?

A. Hilly areas
B. Tropical climate
C. Rainy areas
D. Deserts (Correct Answer)

Explanation: **Explanation:** **Veldt sore**, also known as **Desert sore** or **Barcoo rot**, is a cutaneous manifestation of **Corynebacterium diphtheriae** (non-toxigenic strains). It is characterized by chronic, punched-out ulcers, typically occurring on exposed areas like the hands, forearms, and shins. 1. **Why Deserts (Option D) is correct:** The condition is classically associated with hot, arid, and desert environments. The underlying medical concept involves a combination of factors: minor trauma (abrasions/insect bites) acting as a portal of entry, coupled with poor hygiene and intense solar radiation which delays wound healing. It was historically significant among soldiers serving in desert campaigns (e.g., North Africa during WWII). 2. **Why other options are incorrect:** * **Hilly areas (A):** While trauma can occur here, the specific bacterial colonization and environmental stressors (dry heat) required for Veldt sore are absent. * **Tropical/Rainy areas (B & C):** These environments are more commonly associated with fungal infections (Tinea), Leishmaniasis, or tropical ulcers caused by *Fusobacterium* and *Borrelia*. Veldt sore specifically requires the dry, dusty conditions of the desert. **Clinical Pearls for NEET-PG:** * **Causative Agent:** *Corynebacterium diphtheriae* (most common) or *Staphylococcus aureus*. * **Clinical Morphology:** A painful vesicle that ruptures to form a **punched-out ulcer** with a grayish-green base and undermined edges. * **Differential Diagnosis:** Cutaneous Leishmaniasis (Oriental Sore), which also occurs in deserts but is caused by a protozoan and has a longer incubation period. * **Treatment:** Local wound care and systemic penicillin or erythromycin.

Question 23: What is the recommended treatment for severe ulnar neuritis in borderline tuberculoid leprosy?

A. MDT only
B. MDT + steroid (Correct Answer)
C. Wait and watch
D. MDT + thalidomide

Explanation: **Explanation:** In leprosy, nerve involvement is the primary cause of morbidity. **Ulnar neuritis** in Borderline Tuberculoid (BT) leprosy is typically a manifestation of a **Type 1 Lepra Reaction** (Reversal Reaction). This is a delayed hypersensitivity (Type IV) response where an increase in cell-mediated immunity leads to acute inflammation of the nerves. 1. **Why MDT + Steroids is correct:** While Multi-Drug Therapy (MDT) treats the *Mycobacterium leprae* infection, it does not stop the immunological damage to the nerve. **Systemic corticosteroids** (e.g., Prednisolone) are the gold standard for treating acute neuritis. They reduce endoneural edema and suppress the inflammatory cascade, preventing permanent nerve damage and subsequent physical disability (e.g., claw hand). 2. **Why other options are wrong:** * **MDT only:** MDT kills the bacilli but cannot control the acute immunological reaction. Relying on MDT alone during active neuritis leads to irreversible nerve fibrosis. * **Wait and watch:** Neuritis is a medical emergency in dermatology. Delaying treatment leads to permanent motor and sensory loss. * **MDT + Thalidomide:** Thalidomide is the drug of choice for **Type 2 Lepra Reaction** (Erythema Nodosum Leprosum), which occurs in lepromatous poles. It is ineffective in Type 1 reactions. **High-Yield Clinical Pearls for NEET-PG:** * **Steroid Regimen:** Usually started at 40mg/day (or 1mg/kg) and tapered over 12–24 weeks. * **Silent Neuritis:** Nerve damage occurring without pain or tenderness; it also requires urgent steroid therapy. * **Type 1 Reaction:** Common in BT, BB, and BL leprosy; characterized by "upgrading" of lesions (erythema/edema) and neuritis. * **Ulnar Nerve:** The most common peripheral nerve involved in leprosy.

Question 24: What is the main cytokine involved in the erythema nodosum leprosum reaction?

A. Interleukin 2
B. Interferon gamma
C. Tumour necrosis factor alpha (Correct Answer)
D. Macrophage colony stimulating factor

Explanation: **Explanation:** **Erythema Nodosum Leprosum (ENL)**, also known as a **Type 2 Lepra Reaction**, is a systemic immune-complex-mediated (Gell and Coombs Type III) hypersensitivity reaction occurring primarily in patients with lepromatous (LL) or borderline lepromatous (BL) leprosy. 1. **Why TNF-α is correct:** **Tumour Necrosis Factor-alpha (TNF-α)** is the central mediator in the pathogenesis of ENL. During the reaction, there is a massive release of TNF-α from activated macrophages and monocytes in response to the breakdown of *Mycobacterium leprae*. High serum levels of TNF-α correlate with the clinical severity of the reaction (fever, painful subcutaneous nodules, and neuritis). This is clinically significant because **Thalidomide**, the drug of choice for severe ENL, works primarily by inhibiting TNF-α synthesis. 2. **Why other options are incorrect:** * **Interleukin-2 (IL-2) and Interferon-gamma (IFN-γ):** These are Th1-type cytokines. They are the hallmark of **Type 1 Lepra Reactions** (Reversal Reactions), which involve a shift toward cell-mediated immunity. In ENL, the cytokine profile is predominantly Th2-driven, though TNF-α remains the primary effector. * **Macrophage colony-stimulating factor (M-CSF):** While involved in general macrophage differentiation, it is not a specific or primary mediator of the acute inflammatory cascade seen in ENL. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Type III Hypersensitivity (Immune complex deposition). * **Clinical Features:** Tender evanescent nodules, high-grade fever, arthralgia, and iridocyclitis. * **Drug of Choice:** **Thalidomide** (specifically for ENL, not Type 1). * **Alternative Treatment:** Clofazimine (high dose) or systemic corticosteroids. * **Histopathology:** Shows **leucocytoclastic vasculitis** superimposed on lepromatous features.

Question 25: A saucer-shaped lesion is found in which type of leprosy?

A. Lepromatous leprosy
B. Tuberculoid leprosy
C. Borderline leprosy (Correct Answer)
D. Indeterminate leprosy

Explanation: **Explanation:** The **saucer-shaped lesion** (also known as the "inverted saucer" appearance) is a classic morphological hallmark of **Borderline Tuberculoid (BT)** or **Borderline Borderline (BB)** leprosy. This appearance is characterized by a lesion with a well-defined, raised, and erythematous outer edge that slopes gradually toward a flattened, pale, or hypopigmented center. **Why Borderline Leprosy is correct:** In the Ridley-Jopling classification, borderline cases represent an unstable immunological state. The "saucer" morphology occurs because the body attempts to contain the infection (leading to the raised, active border) but fails to do so completely, resulting in a large, asymmetrical lesion with central clearing or flattening. **Analysis of Incorrect Options:** * **Lepromatous Leprosy (LL):** Presents with multiple, symmetrical, small macules, papules, or nodules (lepromas). The lesions have vague borders and do not show the characteristic saucer shape. * **Tuberculoid Leprosy (TT):** Typically presents as a single (or very few), well-defined, anesthetic, hairless plaque. While the margins are sharp, they do not typically exhibit the specific "sloping" saucer morphology seen in borderline types. * **Indeterminate Leprosy:** This is the earliest stage, presenting as a single, ill-defined hypopigmented macule with vague borders and no significant sensory loss. **High-Yield Clinical Pearls for NEET-PG:** * **Swiss-Cheese Appearance:** Characteristic of **Borderline Borderline (BB)** leprosy, where "punched-out" clear areas appear within a large plaque. * **Leonine Facies:** Seen in **Lepromatous Leprosy (LL)** due to diffuse infiltration of the face. * **Nerve Involvement:** Nerve thickening is most asymmetrical in BT leprosy but most extensive/symmetrical in LL. * **Madarosis:** Loss of the lateral one-third of eyebrows, a classic sign of LL.

Question 26: What type of reaction is seen in Type I Leprosy reaction?

A. Type I
B. Type II
C. Type III
D. Type IV (Correct Answer)

Explanation: **Explanation:** Leprosy reactions are acute inflammatory episodes occurring during the chronic course of the disease. Understanding the underlying immunology is crucial for NEET-PG. **Why Type IV is Correct:** Type I Leprosy Reaction (also known as **Reversal Reaction**) is a **Type IV Hypersensitivity reaction** (Delayed-type hypersensitivity). It occurs due to a sudden increase in cell-mediated immunity (CMI) against *Mycobacterium leprae* antigens. This typically occurs in unstable borderline cases (BT, BB, and BL). Clinically, it manifests as sudden redness and edema of existing skin lesions and acute neuritis (nerve pain and tenderness). **Why other options are incorrect:** * **Type I (IgE-mediated):** This involves immediate hypersensitivity (e.g., anaphylaxis, urticaria), which plays no role in leprosy reactions. * **Type II (Antibody-mediated):** This involves cytotoxic antibodies (e.g., autoimmune hemolytic anemia), not seen in leprosy. * **Type III (Immune-complex mediated):** This is the mechanism for **Type II Leprosy Reaction** (Erythema Nodosum Leprosum or ENL). In ENL, antigen-antibody complexes deposit in tissues, causing systemic symptoms like fever and painful evanescent nodules. **High-Yield Clinical Pearls for NEET-PG:** * **Type I Reaction:** Seen in Borderline leprosy; treated primarily with **Corticosteroids**. It is "Reversal" because the patient moves toward the Tuberculoid pole (upgrading). * **Type II Reaction (ENL):** Seen in LL and BL cases; **Thalidomide** is the drug of choice (except in women of childbearing age). * **Lucio Phenomenon:** A rare, severe Type III reaction seen in diffuse lepromatous leprosy, characterized by necrotizing vasculitis.

Question 27: Type 1 lepra reaction is treated with?

A. Corticosteroid (Correct Answer)
B. Minocycline
C. Dapsone
D. Rifampicin

Explanation: **Explanation:** **Type 1 Lepra Reaction (Reversal Reaction)** is a Delayed Hypersensitivity (Type IV) reaction occurring in borderline cases of leprosy (BT, BB, BL). It is characterized by acute inflammation of existing skin lesions and, more critically, **acute neuritis**. 1. **Why Corticosteroids are the Correct Answer:** The primary goal in managing Type 1 reactions is to suppress the cell-mediated immune response to prevent irreversible nerve damage and physical deformity. **Systemic Corticosteroids (Prednisolone)** are the gold standard treatment. They act rapidly to reduce edema and inflammation within the nerve sheath, thereby preventing permanent axonal loss. The typical regimen involves a tapering dose of Prednisolone over 3–6 months. 2. **Why Other Options are Incorrect:** * **Minocycline, Dapsone, and Rifampicin:** These are bactericidal/bacteriostatic antibiotics used in **Multi-Drug Therapy (MDT)** to kill *Mycobacterium leprae*. While MDT should be continued during a reaction, these drugs do not treat the immunological flare itself. In fact, starting MDT can sometimes trigger a Type 1 reaction by releasing bacterial antigens. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Type 2 Reaction (ENL):** Thalidomide (for severe/recurrent cases) or Corticosteroids. * **Key Clinical Sign:** Sudden redness/swelling of old lesions + new onset nerve tenderness/loss of function. * **Management Tip:** Never stop MDT during a lepra reaction. * **Clofazimine:** While primarily an antileprotic, it has anti-inflammatory properties and is used as a steroid-sparing agent in Type 2 reactions, but it is less effective for the acute phase of Type 1 reactions.

Question 28: Ainhum is typically seen at which anatomical location?

A. Base of the great toe
B. Fingertips
C. Base of the toes (Correct Answer)
D. Ankle

Explanation: **Explanation:** **Ainhum** (also known as *Dactylolysis Spontanea*) is a rare clinical condition characterized by the formation of a tight, constricting fibrous band around the digit. **Why the correct answer is right:** The condition typically occurs at the **base of the toes**, most commonly involving the **fifth (little) toe**. The constriction begins in the digito-plantar fold and progresses circumferentially. Over time, this fibrous band leads to progressive ischemia, bone resorption (rarefaction), and eventual spontaneous auto-amputation of the digit. It is most frequently seen in individuals of African descent living in tropical climates. **Why the incorrect options are wrong:** * **Base of the great toe:** While Ainhum affects the toes, it almost exclusively targets the fifth toe; the great toe is rarely, if ever, the primary site. * **Fingertips:** Ainhum is a disease of the lower extremities. Constrictions on the fingers are usually associated with "Pseudo-ainhum," which is secondary to other conditions like leprosy, scleroderma, or Vohwinkel syndrome. * **Ankle:** Ainhum is a digital pathology. Constrictions at the ankle are not a feature of this condition. **NEET-PG High-Yield Pearls:** * **Pseudo-ainhum:** Unlike true Ainhum, this is secondary to systemic diseases (e.g., Psoriasis, Diabetes, Leprosy) or congenital bands (Streeter’s dysplasia). * **Radiological Sign:** The "hook-like" appearance of the distal phalanx or narrowing of the shaft of the phalanx is characteristic. * **Staging:** It follows four clinical stages, ending in auto-amputation. * **Treatment:** Early stages may be treated with Z-plasty; late stages require surgical amputation if auto-amputation is painful.

Question 29: What is the characteristic feature of borderline leprosy?

A. Inverted saucer lesion (Correct Answer)
B. Erythema nodosum leprosum (ENL)
C. Hypopigmented macules and plaques all over the body
D. Glove and stocking anesthesia

Explanation: **Explanation:** In leprosy, the clinical presentation depends on the host's cell-mediated immunity (CMI). **Borderline Leprosy (specifically Borderline Tuberculoid or Borderline Borderline)** is characterized by lesions that are unstable and show features of both ends of the spectrum. **Why Option A is correct:** The **"Inverted Saucer" lesion** (also known as a "Swiss Cheese" appearance) is a classic morphological feature of **Borderline Borderline (BB) leprosy**. These lesions are typically annular or oval plaques with a punched-out, clear center and a sloping outer edge, resembling an inverted saucer. This occurs due to the partial immune response attempting to clear the center of the lesion. **Why the other options are incorrect:** * **Option B (ENL):** Erythema Nodosum Leprosum is a Type 2 Lepra reaction, which is classically seen in **Lepromatous Leprosy (LL)** or near-lepromatous (BL) cases, not typically in the borderline spectrum. * **Option C (Hypopigmented macules all over):** While borderline leprosy has multiple lesions, "all over the body" with symmetrical distribution and numerous small macules is more characteristic of **Lepromatous Leprosy (LL)**. * **Option D (Glove and stocking anesthesia):** This is a feature of distal symmetrical polyneuropathy, most commonly associated with **Lepromatous Leprosy (LL)** due to widespread nerve involvement. **High-Yield Clinical Pearls for NEET-PG:** * **BB Leprosy:** Most unstable form; can shift toward BT (reversal reaction) or BL (downgrading). * **Satellite Lesions:** Small lesions near a larger plaque; highly suggestive of **Borderline Tuberculoid (BT)** leprosy. * **Leonine Facies:** Characteristic of **Lepromatous Leprosy (LL)** due to diffuse infiltration of the face. * **Nerve Involvement:** In Borderline leprosy, nerve involvement is often **asymmetrical** and can be sudden/severe during reactions.

Question 30: The constriction in Ainhum develops usually at which interphalangeal joint?

A. Great toe
B. Little toe (Correct Answer)
C. Thumb
D. Little finger

Explanation: **Explanation:** **Ainhum (Dactylolysis Spontanea)** is a rare, idiopathic condition characterized by the formation of a progressive, constricting fibrous band around the base of a digit. **Why the Little Toe is Correct:** The classic site for Ainhum is the **proximal interphalangeal joint of the fifth (little) toe**. The constriction begins as a groove on the medial or plantar-lateral aspect of the digit, eventually encircling it. This leads to progressive ischemia, bone resorption (rarefaction), and spontaneous auto-amputation. It is most commonly seen in individuals of African descent who walk barefoot in tropical climates. **Analysis of Incorrect Options:** * **Great toe (A):** While other toes can occasionally be involved, the great toe is rarely affected in true Ainhum. * **Thumb (C) & Little finger (D):** Ainhum specifically refers to the toes. Constrictions involving the fingers or multiple digits are typically referred to as **Pseudo-ainhum**, which is associated with genetic conditions (like Vohwinkel syndrome or Mal de Meleda) or physical trauma (like hair-thread tourniquet syndrome). **High-Yield Clinical Pearls for NEET-PG:** * **Radiological Sign:** The "distal tapering" or "conical thinning" of the phalanges (osteolysis) is a characteristic X-ray finding. * **Staging:** It progresses through four stages, ending in auto-amputation. * **Pseudo-ainhum:** Always differentiate from true Ainhum. Pseudo-ainhum is secondary to other conditions (e.g., Leprosy, Psoriasis, Scleroderma, or Keratodermas). * **Treatment:** In early stages, Z-plasty can be performed; late stages require surgical amputation if the digit is painful or non-viable.

Question 31: Which is the main cytokine involved in erythema nodosum leprosum (ENL) reaction?

A. Interleukin-2
B. Interferon-gamma
C. Tumor necrosis factor-alpha (Correct Answer)
D. Macrophage colony stimulating factor

Explanation: **Explanation:** **Erythema Nodosum Leprosum (ENL)**, also known as a **Type 2 Lepra Reaction**, is a systemic immune-complex-mediated (Gell and Coombs Type III) hypersensitivity reaction occurring primarily in lepromatous (LL) and borderline lepromatous (BL) leprosy. **Why TNF-alpha is the correct answer:** The hallmark of ENL is an acute inflammatory response characterized by high levels of circulating **Tumor Necrosis Factor-alpha (TNF-α)**. TNF-α is released by activated macrophages and is responsible for the systemic symptoms (fever, malaise) and the characteristic painful, evanescent skin nodules. The clinical efficacy of **Thalidomide**—the drug of choice for severe ENL—is specifically due to its ability to inhibit TNF-α mRNA, further proving this cytokine's central role. **Why the other options are incorrect:** * **Interleukin-2 (IL-2) and Interferon-gamma (IFN-γ):** These are Th1-type cytokines. They are predominantly involved in **Type 1 Lepra Reactions** (Reversal Reactions), which involve a shift toward cell-mediated immunity. * **Macrophage Colony Stimulating Factor (M-CSF):** While involved in general macrophage differentiation, it is not a primary mediator or diagnostic marker for the acute inflammatory cascade of ENL. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Type III Hypersensitivity (Immune-complex deposition). * **Clinical Features:** Tender erythematous nodules, fever, neuritis, arthritis, and iridocyclitis. * **Drug of Choice:** **Thalidomide** (Severe/Chronic ENL); **Corticosteroids** (Acute/Mild). * **Histopathology:** Shows **Leukocytoclastic vasculitis** with a neutrophilic infiltrate superimposed on a foam-cell (Virchow cell) background. * **Trigger:** Often precipitated by the initiation of Multi-Drug Therapy (MDT).

Question 32: What is the main cytokine involved in erythema nodosum leprosum (ENL) reaction?

A. Interleukin-2
B. Interferon-gamma
C. Tumor necrosis factor-alpha (Correct Answer)
D. Macrophage colony stimulating factor

Explanation: **Explanation:** **Erythema Nodosum Leprosum (ENL)**, or Type 2 Lepra Reaction, is a classic example of a **Type III hypersensitivity reaction** (immune-complex mediated). It occurs primarily in patients with multibacillary leprosy (lepromatous or borderline lepromatous) due to the sudden release of antigens from killed *Mycobacterium leprae*. **Why TNF-alpha is the correct answer:** **Tumor Necrosis Factor-alpha (TNF-α)** is the central mediator in the pathogenesis of ENL. During the reaction, there is a massive systemic release of TNF-α from activated macrophages and monocytes. This cytokine is responsible for the systemic symptoms (fever, malaise) and the characteristic painful, evanescent subcutaneous nodules. The clinical efficacy of **Thalidomide**—the drug of choice for severe ENL—is specifically due to its ability to inhibit TNF-α mRNA. **Why other options are incorrect:** * **Interleukin-2 (IL-2) and Interferon-gamma (IFN-γ):** These are Th1-type cytokines. They are predominantly involved in **Type 1 Lepra Reactions** (Reversal Reaction), which represent a delayed-type hypersensitivity (Type IV) response and an increase in cell-mediated immunity. * **Macrophage colony-stimulating factor (M-CSF):** While involved in general macrophage maturation, it does not play a primary role in the acute inflammatory cascade of ENL. **High-Yield Clinical Pearls for NEET-PG:** * **Type 2 Reaction (ENL):** Occurs in LL and BL leprosy; characterized by painful crops of nodules, fever, iridocyclitis, neuritis, and orchitis. * **Drug of Choice:** **Thalidomide** (fastest acting); Steroids are used if thalidomide is contraindicated or for neuritis. **Clofazimine** is used for chronic ENL. * **Histopathology:** Shows **Leukocytoclastic vasculitis** with an influx of neutrophils (unlike Type 1, which shows increased granuloma formation).

Question 33: Which peripheral nerve is most commonly affected in leprosy?

A. Ulnar nerve (Correct Answer)
B. Radial nerve
C. Median nerve
D. Lateral popliteal nerve

Explanation: **Explanation:** Leprosy (*Hansen’s Disease*), caused by *Mycobacterium leprae*, has a unique predilection for peripheral nerves. The bacteria thrive in cooler temperatures (30–33°C), which explains why they preferentially involve superficial nerve trunks located close to the skin surface. **1. Why Ulnar Nerve is Correct:** The **ulnar nerve** is the most commonly affected peripheral nerve in leprosy. It is typically involved at the elbow, just proximal to the olecranon groove (cubital tunnel). Damage leads to sensory loss in the little finger and medial half of the ring finger, and motor weakness resulting in the characteristic **"partial claw hand"** (ape hand). **2. Analysis of Incorrect Options:** * **Radial Nerve:** While frequently involved, it is less common than the ulnar nerve. Involvement usually occurs at the spiral groove, leading to **wrist drop**. * **Median Nerve:** Often involved in conjunction with the ulnar nerve (especially in Borderline Tuberculoid cases), leading to a **"total claw hand"** and "ape thumb" deformity. It is rarely the *most* common or the first nerve affected. * **Lateral Popliteal Nerve (Common Peroneal):** This is the **most commonly affected nerve in the lower limb**. It is involved at the neck of the fibula, leading to **foot drop**. **Clinical Pearls for NEET-PG:** * **Order of involvement (Upper Limb):** Ulnar > Median > Radial. * **Order of involvement (Lower Limb):** Lateral Popliteal > Posterior Tibial. * **Thickest Nerve:** The **Greater Auricular Nerve** is often cited as the most commonly *palpably* enlarged nerve in the head and neck region. * **Facial Nerve:** Involvement leads to lagophthalmos (inability to close the eye), a high-yield clinical sign. * **Nerve Abscess:** Most commonly seen in the **Ulnar nerve** in Tuberculoid (TT) or Borderline Tuberculoid (BT) leprosy.

Question 34: A 7-year-old child presents with a hypopigmented, anesthetic patch on the face. What is the most probable diagnosis?

A. Intermediate leprosy (Correct Answer)
B. Pityriasis alba
C. Nevus anemicus
D. Nevus achromicus

Explanation: **Explanation:** The diagnosis of **Indeterminate Leprosy** (often referred to in exams as Intermediate leprosy) is based on the classic clinical triad of leprosy: a hypopigmented patch, loss of sensation, and (potentially) nerve involvement. In a pediatric patient, a solitary, ill-defined hypopigmented macule on the face with **definite anesthesia** is pathognomonic for early leprosy. This stage represents the earliest clinical manifestation where the host's cell-mediated immunity is yet to determine the specific polar type (Tuberculoid vs. Lepromatous). **Why the other options are incorrect:** * **Pityriasis alba:** Common in children; presents as scaly, hypopigmented patches on the face. However, **sensation is always intact**, and it is often associated with atopy. * **Nevus anemicus:** A congenital vascular anomaly. The area appears pale due to localized hypersensitivity to catecholamines (vasoconstriction), not a loss of pigment. Sensation is normal, and the patch "disappears" on diascopy (pressure). * **Nevus achromicus (Nevus depigmentosus):** A congenital stable hypopigmented patch present since birth. It has normal sensation and does not change in size relative to body growth. **High-Yield Clinical Pearls for NEET-PG:** * **Cardinal Signs of Leprosy (WHO):** 1. Hypopigmented/reddish patch with definite loss of sensation. 2. Thickened peripheral nerves. 3. Positive skin smear for acid-fast bacilli. * **Face involvement:** In children, the face is the most common site for indeterminate leprosy. * **Sensory Loss Pattern:** Temperature (cold/hot) is lost first, followed by touch, pain, and lastly, deep pressure. * **Histopathology:** Indeterminate leprosy shows non-specific perivascular and periappendageal lymphocytic infiltration; granulomas are not yet formed.

Question 35: All the features of peripheral neuritis in a patient with Hansen's disease EXCEPT?

A. Predominant sensory involvement
B. Decreased tendon reflexes (Correct Answer)
C. Mutilations
D. Peripheral nerve thickening

Explanation: In Hansen’s disease (Leprosy), peripheral neuritis is a hallmark feature caused by the invasion of *Mycobacterium leprae* into Schwann cells. ### **Why "Decreased Tendon Reflexes" is the Correct Answer** In leprosy, the nerve damage is primarily a **mononeuritis multiplex** affecting the **distal, smaller nerve branches** and cutaneous twigs. Deep Tendon Reflexes (DTRs) are mediated by large-diameter fibers and spinal arcs that remain intact until the very late, terminal stages of the disease. Therefore, even in a limb with significant sensory loss or muscle atrophy, the **tendon reflexes are characteristically preserved.** If reflexes are absent early on, one should consider other neuropathies like CIDP or Vitamin B12 deficiency. ### **Explanation of Other Options** * **A. Predominant sensory involvement:** This is a classic feature. Leprosy typically follows a sequence of sensory loss (temperature → pain → touch) before motor involvement occurs. * **C. Mutilations:** These are secondary complications of neuritis. Loss of protective sensation leads to repetitive microtrauma, secondary infections, and resorption of phalanges (auto-amputation). * **D. Peripheral nerve thickening:** This is a cardinal sign of leprosy. The inflammatory response to the bacilli causes palpable enlargement of nerves at sites of predilection (e.g., Ulnar nerve above the elbow, Common Peroneal nerve at the fibular head). ### **NEET-PG High-Yield Pearls** * **Most common nerve involved:** Ulnar nerve. * **Most common nerve involved in the face:** Zygomatic branch of the Facial nerve (leads to lagophthalmos). * **Sequence of sensory loss:** Temperature (cold then hot) → Pain → Light touch. * **Nerve Abscess:** Most commonly seen in the **Ulnar nerve** in BT (Borderline Tuberculoid) leprosy. * **Pure Neuritic Leprosy:** Diagnosed by nerve thickening and sensory loss without any visible skin lesions; usually requires a nerve biopsy for confirmation.

Question 36: What is the treatment for lepra reaction with acute neuritis?

A. Prednisolone (Correct Answer)
B. Thalidomide
C. Clofazimine
D. Dapsone

Explanation: **Explanation:** The management of lepra reactions (Type 1 and Type 2) depends heavily on the presence of nerve involvement. **Acute neuritis** is a medical emergency in leprosy because it can lead to permanent paralysis and deformity within hours or days. **1. Why Prednisolone is Correct:** Systemic corticosteroids, specifically **Prednisolone**, are the gold standard for treating acute neuritis in both Type 1 (Reversal) and Type 2 (ENL) reactions. Corticosteroids act by reducing intraneural edema and suppressing the cell-mediated immune response that causes nerve damage. Prompt initiation of steroids (usually starting at 40–60 mg/day) is essential to prevent irreversible nerve trunk damage. **2. Why the other options are incorrect:** * **Thalidomide:** While highly effective for severe **Type 2 reactions (ENL)**, it is slow to act on nerve inflammation and is **not** the first-line treatment for acute neuritis. It is also contraindicated in Type 1 reactions and pregnancy. * **Clofazimine:** This drug has anti-inflammatory properties and is used as a steroid-sparing agent in chronic ENL, but its onset of action is too slow (weeks) for the management of acute neuritis. * **Dapsone:** This is a bacteriostatic component of Multi-Drug Therapy (MDT). It has no role in managing acute immunological reactions and can occasionally trigger them. **High-Yield Clinical Pearls for NEET-PG:** * **Type 1 Reaction:** Delayed hypersensitivity (Type IV); seen in BT, BB, BL leprosy. * **Type 2 Reaction (ENL):** Immune complex-mediated (Type III); seen in BL and LL leprosy. * **Silent Neuritis:** Nerve damage occurring without pain or tenderness; also treated with Prednisolone. * **MDT Policy:** Never stop MDT during a lepra reaction; continue the standard regimen alongside steroids.

Question 37: All are features of lepromatous leprosy except?

A. Gynaecomastia
B. Madarosis
C. Saddle nose
D. Perforating Ulcer (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Perforating Ulcer**. In Leprosy, **Perforating Ulcers** (trophic ulcers) are a hallmark of **Tuberculoid Leprosy (TT/BT)**. These occur due to anesthesia resulting from early, asymmetric, and severe nerve damage. In contrast, Lepromatous Leprosy (LL) is characterized by high bacterial load but delayed nerve damage; anesthesia occurs much later and is usually symmetrical (glove-and-stocking distribution), making trophic ulcers less characteristic of the early-to-mid clinical presentation of LL. **Analysis of Incorrect Options:** * **Gynaecomastia:** This is a classic feature of LL. It occurs due to testicular atrophy caused by direct *M. leprae* infiltration (orchitis), leading to a hormonal imbalance (decreased testosterone and increased estrogen). * **Madarosis:** This refers to the loss of eyebrows (specifically the lateral one-third). It is a common feature of LL due to the infiltration of lepromas into the hair follicles. * **Saddle nose:** In LL, the bacilli infiltrate the nasal mucosa and cartilage, leading to chronic rhinitis, crusting, and eventually destruction of the nasal septum, causing the bridge of the nose to collapse. **High-Yield Clinical Pearls for NEET-PG:** * **LL Hallmark:** Bilateral symmetrical lesions, Leonine facies, and "Glove and Stocking" anesthesia. * **TT Hallmark:** Asymmetrical, well-defined anesthetic patches with early nerve enlargement. * **Bacteriology:** LL is Multibacillary (BI 3+ to 6+), while TT is Paucibacillary (BI 0 to 1+). * **Internal Organ Involvement:** LL involves the reticuloendothelial system, liver, spleen, and testes; TT is limited to skin and nerves.

Question 38: Which of the following is a characteristic feature of borderline leprosy?

A. Extensive glove and stocking anesthesia
B. Inveed saucer shaped lesions (Correct Answer)
C. Erythema nodosum leprosum
D. Facial lesions

Explanation: **Explanation:** Borderline Leprosy (specifically **Borderline Tuberculoid (BT)** and **Mid-Borderline (BB)**) represents an unstable immunological state between the polar ends of the Ridley-Jopling scale. **Why Option B is correct:** The **"Inverted Saucer"** appearance is a pathognomonic clinical feature of **Mid-Borderline (BB) leprosy**. These lesions are characterized by large, erythematous plaques with a well-defined inner edge and a hazy, sloping outer edge. This morphology occurs because the central area of the lesion starts to clear or flatten while the periphery remains active and raised, resembling an upside-down saucer. **Why other options are incorrect:** * **Option A (Glove and stocking anesthesia):** This is a characteristic feature of **Lepromatous Leprosy (LL)**. In LL, there is widespread, symmetrical nerve involvement leading to distal sensory loss in the extremities. * **Option C (Erythema Nodosum Leprosum - ENL):** This is a **Type 2 Lepra Reaction**, which occurs almost exclusively in the multibacillary poles (**BL and LL**) due to immune complex deposition. It is not a primary feature of the borderline spectrum itself. * **Option D (Facial lesions):** While facial lesions can occur in many types of leprosy, they are most classically associated with the "Leonine Facies" of **Lepromatous Leprosy (LL)** due to diffuse infiltration. **High-Yield Clinical Pearls for NEET-PG:** * **BB Leprosy:** The most unstable form; it can shift toward either the Tuberculoid or Lepromatous pole. * **Punch-out lesions:** Another term used for BB lesions with clear central areas. * **Type 1 Reaction:** Most common in Borderline types (BT, BB, BL) due to changes in Cell-Mediated Immunity (CMI). * **Satellite Lesions:** Small lesions found near a larger plaque, highly characteristic of **Borderline Tuberculoid (BT)** leprosy.

Question 39: An 8-year-old boy presents with a 6-month history of an ill-defined, hypopigmented, slightly atrophic macule on the face. What is the most likely diagnosis?

A. Pityriasis alba
B. Indeterminate leprosy (Correct Answer)
C. Morphoea
D. Calcium deficiency

Explanation: **Explanation:** The correct diagnosis is **Indeterminate Leprosy**. In the context of the NEET-PG exam, any solitary, ill-defined, hypopigmented macule in a child living in an endemic area should be considered leprosy until proven otherwise. **Why Indeterminate Leprosy is correct:** Indeterminate leprosy is the earliest clinical stage of the disease. It typically presents as a **single, ill-defined, hypopigmented macule** with minimal or no sensory loss (as nerve damage is not yet advanced). While atrophy is more common in late-stage tuberculoid leprosy, early trophic changes or subtle texture alterations can occur. In pediatric cases, the face is a common site of involvement. **Why other options are incorrect:** * **Pityriasis alba:** Presents as multiple, scaly, hypopigmented patches with fuzzy borders, usually associated with atopy. It does **not** cause atrophy. * **Morphoea (Localized Scleroderma):** While it causes atrophy, the initial stage is usually a violaceous or "lilac" patch that progresses to a firm, ivory-white sclerotic plaque. It is not primarily a hypopigmented macule. * **Calcium deficiency:** This is a common **myth**. Nutritional deficiencies (like Vitamin A or Calcium) do not cause localized, atrophic hypopigmented macules on the face. **Clinical Pearls for NEET-PG:** * **Cardinal Signs of Leprosy:** Hypopigmented/reddish patch with (1) definite loss of sensation, (2) thickened nerves, or (3) positive skin smear for AFB. * **Indeterminate Leprosy Histology:** Shows non-specific lymphocytic infiltration around skin appendages and nerves; Lepra bacilli are rarely found. * **Prognosis:** Most cases of indeterminate leprosy in children self-heal, but some progress to the determinate spectrum (TT, BT, BB, BL, or LL).

Question 40: Esthiomene is seen in which of the following conditions?

A. Chancroid
B. Syphilis
C. Lymphogranuloma Venereum (LGV) (Correct Answer)
D. Gonorrhoea

Explanation: **Explanation:** **Esthiomene** is a late-stage chronic manifestation of **Lymphogranuloma Venereum (LGV)**, caused by *Chlamydia trachomatis* (serotypes L1, L2, and L3). The underlying mechanism involves chronic lymphatic obstruction and persistent inflammation. In the tertiary stage of LGV, extensive destruction of the lymphatic vessels leads to chronic lymphedema, resulting in massive, painful, and disfiguring swelling of the external genitalia (vulva in females, scrotum/penis in males), often accompanied by ulceration and fistulae. **Analysis of Options:** * **Chancroid (Option A):** Caused by *Haemophilus ducreyi*, it presents with painful "soft" ulcers and painful inguinal lymphadenopathy (buboes), but does not cause chronic lymphatic obstruction or esthiomene. * **Syphilis (Option B):** Caused by *Treponema pallidum*. Primary syphilis presents with a painless "hard" chancre. While tertiary syphilis can cause gummas, it does not typically result in genital elephantiasis. * **Gonorrhoea (Option C):** Caused by *Neisseria gonorrhoeae*, it primarily presents as urethritis or cervicitis. It does not involve the lymphatic system in a way that leads to esthiomene. **High-Yield Clinical Pearls for NEET-PG:** * **LGV Stages:** 1. Primary: Small, painless transient papule/ulcer. 2. Secondary: **Groove Sign** (inguinal ligament dividing matted lymph nodes). 3. Tertiary: **Esthiomene** (genito-anorectal syndrome). * **Drug of Choice for LGV:** Doxycycline (100 mg BID for 21 days). * **Differential Diagnosis:** Esthiomene must be differentiated from **Donovanosis** (Granuloma Inguinale), which presents with "beefy red" ulcers but lacks significant lymphadenopathy.

Question 41: What is the drug of choice for Erythema Nodosum Leprosum?

A. Steroids (Correct Answer)
B. Thalidomide
C. Clofazimine
D. Aspirin

Explanation: **Explanation:** **Erythema Nodosum Leprosum (ENL)**, also known as a **Type 2 Lepra Reaction**, is a Type III hypersensitivity reaction (immune-complex mediated) occurring primarily in Lepromatous (LL) and Borderline Lepromatous (BL) leprosy. **Why Steroids are the Correct Answer:** Systemic **Corticosteroids (Prednisolone)** are the **first-line drug of choice** for managing ENL. They are preferred because they provide rapid control of acute inflammation, stabilize lysosomal membranes, and prevent nerve damage. In the context of NEET-PG, unless the question specifically asks for the "most effective" or "drug for recurrent/chronic ENL," steroids remain the standard initial treatment. **Analysis of Incorrect Options:** * **B. Thalidomide:** While Thalidomide is the **most effective** drug for ENL and the treatment of choice for chronic/recurrent cases, it is not the first-line choice due to its severe **teratogenicity** (phocomelia) and restricted availability. * **C. Clofazimine:** This drug has anti-inflammatory properties and is used as a **steroid-sparing agent** in chronic ENL. However, it has a slow onset of action (takes 4–6 weeks) and is not suitable for acute management. * **D. Aspirin:** Used only for very **mild** cases of ENL to manage pain and fever; it cannot control the systemic immune response in moderate to severe reactions. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Type 2 reaction involves Arthus-type phenomenon with deposition of Ag-Ab complexes and TNF-α release. * **Clinical Feature:** Characterized by tender, evanescent, erythematous nodules, fever, and systemic involvement (neuritis, orchitis, iridocyclitis). * **Thalidomide Contraindication:** Strictly contraindicated in women of childbearing age. * **MDT Status:** During a lepra reaction, **never stop** the Multi-Drug Therapy (MDT).

Question 42: All of the following are true regarding erythrocyanosis frigida, EXCEPT:

A. Seen exclusively in alcoholic males (Correct Answer)
B. Occurs in the lower third of leg on leg or ankle
C. Causes Bazin's ulcer
D. Sympathectomy may be beneficial in some patients

Explanation: **Explanation:** **Erythrocyanosis frigida** (also known as *erythrocyanosis crurum puellarum frigida*) is a localized vascular disorder caused by an abnormal response to cold. **1. Why Option A is the Correct Answer (The Exception):** The statement is false because the condition is seen **almost exclusively in young women**, particularly those with "heavy" or fat legs. It is not associated with alcoholic males. The pathogenesis involves cold-induced vasospasm of the arterioles followed by secondary dilatation of the capillaries and venules in areas with thick subcutaneous fat. **2. Analysis of Other Options:** * **Option B:** It characteristically involves the **lower third of the leg**, the ankles, and sometimes the posterior aspect of the calves. The affected skin appears dusky, cyanotic, and cold to the touch. * **Option C:** Severe cases can lead to the formation of painful, chronic ulcers known as **Bazin’s ulcers** (Erythema Induratum). While Bazin's disease is traditionally associated with tuberculosis, the term is also used for the ulcerative stage of erythrocyanosis. * **Option D:** Treatment focuses on keeping the limbs warm. However, in severe or refractory cases, **lumbar sympathectomy** may be beneficial to improve peripheral blood flow and promote healing of ulcers. **Clinical Pearls for NEET-PG:** * **Triad of Erythrocyanosis:** Coldness, cyanosis (bluish-red discoloration), and swelling. * **Differential Diagnosis:** Must be distinguished from **Chilblains** (Pernio), which presents as itchy/burning papules on fingers/toes, and **Livedo Reticularis**. * **Key Demographic:** Think "Young females with thick legs in cold climates."

Question 43: Which of the following statements about Yaws is not true?

A. Spread by sexual transmission (Correct Answer)
B. Caused by Treponema pallidum pertenue
C. Has cross immunity with syphilis
D. Cannot be differentiated serologically from T. pallidum

Explanation: **Explanation:** **Yaws** is a chronic, non-venereal treponematosis caused by the bacterium *Treponema pallidum pertenue*. 1. **Why Option A is correct:** Unlike Syphilis, Yaws is **not** a sexually transmitted infection. It is primarily a disease of childhood (usually under 15 years) and is transmitted through **direct skin-to-skin contact** with infectious lesions. It thrives in warm, humid, tropical environments where poor hygiene and overcrowding are prevalent. 2. **Why the other options are wrong:** * **Option B:** This is a true statement. The causative agent is *T. pallidum pertenue*, which is morphologically identical to the agent of syphilis. * **Option C:** This is true. Infection with Yaws provides a degree of **cross-immunity** against syphilis, which is why venereal syphilis was historically less common in areas where Yaws was endemic. * **Option D:** This is true. Because the organisms are so closely related, standard serological tests (both non-treponemal like **VDRL/RPR** and treponemal like **TPHA/FTA-ABS**) cannot distinguish between Yaws and Syphilis. Diagnosis relies on clinical presentation and epidemiological history. **High-Yield Clinical Pearls for NEET-PG:** * **Stages:** Primary (Mother Yaw/Frambesioma), Secondary (Daughter Yaws), and Tertiary (Goundou – swelling of nasal bones; Gangosa – destructive rhinopharyngitis). * **Bone Involvement:** Saber shin (periostitis) is a common late feature. * **Treatment:** A single dose of **Oral Azithromycin** is now the preferred treatment (WHO Morges Strategy), replacing injectable Penicillin G Benzathine. * **Target:** Yaws is targeted by the WHO for global eradication.

Question 44: All of the following are characteristic features of lepromatous leprosy except?

A. Presence of globi
B. Subepidermal free zone
C. Decreased cell-mediated immunity
D. Presence of granulomas subdermally (Correct Answer)

Explanation: In Lepromatous Leprosy (LL), the immune system fails to mount an effective response against *Mycobacterium leprae*, leading to specific histopathological and immunological findings. **Why Option D is the Correct Answer:** In LL, the characteristic finding is a **diffuse dermal infiltration** of foamy macrophages (Virchow cells) laden with bacilli. True **granulomas** (organized collections of epithelioid cells, lymphocytes, and giant cells) are a hallmark of **Tuberculoid Leprosy (TT)**, where cell-mediated immunity (CMI) is strong. In LL, the lack of CMI prevents the formation of organized granulomas. **Explanation of Incorrect Options:** * **A. Presence of globi:** Due to high bacterial load (multibacillary), acid-fast bacilli (AFB) aggregate in large clumps within macrophages; these are called globi. * **B. Subepidermal free zone (Grenz zone):** This is a classic histopathological feature of LL. It is a thin layer of normal collagen separating the epidermis from the underlying dermal infiltrate, caused by the lack of a delayed-type hypersensitivity reaction. * **C. Decreased cell-mediated immunity:** LL represents the Th2-dominant pole of the spectrum. There is a specific anergy to *M. leprae* antigens, resulting in a negative Lepromin test. **NEET-PG High-Yield Pearls:** * **Leonine Facies:** Caused by diffuse infiltration of the face in LL. * **Lepromin Test:** Strongly positive in TT (strong CMI) and **negative** in LL (absent CMI). * **Nerve Involvement:** In LL, nerve involvement is **symmetrical** and occurs late, whereas in TT, it is **asymmetrical** and occurs early. * **Foamy Macrophages:** Also known as Lepra cells or Virchow cells.

Question 45: Type 2 lepra reaction is an example of which type of hypersensitivity reaction?

A. Type 1 hypersensitivity reaction
B. Type 2 hypersensitivity reaction
C. Type 3 hypersensitivity reaction (Correct Answer)
D. Type 4 hypersensitivity reaction

Explanation: **Explanation:** **Type 2 Lepra Reaction (Erythema Nodosum Leprosum - ENL)** is a classic example of a **Type 3 Hypersensitivity Reaction**, which is mediated by the deposition of **immune complexes**. In patients with multibacillary leprosy (BL and LL), there is a high bacterial load and high levels of circulating antigens. When chemotherapy (MDT) is initiated, rapid killing of bacilli releases massive amounts of antigens that react with circulating antibodies to form antigen-antibody complexes. These complexes deposit in small blood vessels, activate the complement system, and lead to **vasculitis**. This manifests clinically as painful, evanescent erythematous nodules, fever, arthralgia, and neuritis. **Analysis of Incorrect Options:** * **Option A (Type 1):** This is IgE-mediated (anaphylactic) hypersensitivity. It is not involved in leprosy reactions. * **Option B (Type 2):** This involves antibody-mediated cytotoxic reactions (e.g., autoimmune hemolytic anemia). While the name "Type 2 Lepra Reaction" is similar, the mechanism is different. * **Option D (Type 4):** This is delayed-type hypersensitivity (cell-mediated). This is the mechanism for **Type 1 Lepra Reaction (Reversal Reaction)**, where a sudden increase in cell-mediated immunity occurs. **High-Yield Clinical Pearls for NEET-PG:** * **Trigger:** Usually occurs after starting MDT (due to antigen release), but can occur spontaneously. * **Key Cytokine:** **TNF-alpha** plays a central role in the pathogenesis of ENL. * **Drug of Choice:** **Thalidomide** is the most effective treatment for Type 2 reactions. Oral corticosteroids are also used. * **Systemic Involvement:** Unlike Type 1 reactions (which are localized to skin/nerves), Type 2 reactions are systemic and can cause iridocyclitis, orchitis, and glomerulonephritis.

Question 46: What is true about ROM therapy?

A. For a single lesion
B. Minocycline is used
C. A single dose is given
D. All the above (Correct Answer)

Explanation: **ROM Therapy** (Rifampicin, Ofloxacin, and Minocycline) is a specialized WHO-recommended treatment regimen designed specifically for **Single Lesion Paucibacillary (SLPB) Leprosy**. ### **Explanation of Options:** * **A. For a single lesion:** ROM therapy is indicated only for patients presenting with a single skin lesion that lacks nerve trunk involvement. This is classified as SLPB leprosy. * **B. Minocycline is used:** The regimen consists of a fixed-dose combination of three potent bactericidal drugs: 1. **R**ifampicin (600 mg) 2. **O**floxacin (400 mg) 3. **M**inocycline (100 mg) * **C. A single dose is given:** Unlike standard Multi-Drug Therapy (MDT) which lasts for months, ROM therapy is administered as a **stat (single) dose** under supervision. Since all three statements accurately describe the protocol, **Option D (All the above)** is correct. ### **Clinical Pearls for NEET-PG:** * **Inclusion Criteria:** The patient must have a single skin lesion with definite sensory loss but **no** enlarged nerves. * **Contraindications:** ROM therapy is generally avoided in children under 5 years and pregnant women (due to the side effects of Ofloxacin and Minocycline on bone/teeth development). * **U-MDT (Uniform MDT):** Do not confuse ROM with U-MDT. U-MDT is a 6-month regimen (Rifampicin + Dapsone + Clofazimine) proposed to treat both PB and MB leprosy patients to simplify logistics. * **Drug of Choice:** While ROM is an option for SLPB, the standard WHO MDT (6 months of Rifampicin + Dapsone) remains the gold standard for Paucibacillary leprosy.

Question 47: Immune-mediated destruction of tissue bearing a high concentration of Mycobacterium leprae bacilli occurs, usually several months after the initiation of effective therapy. This results in cutaneous ulcers in patients with lepromatous leprosy. What is this phenomenon called?

A. Raynaud's phenomenon
B. Placebo phenomenon
C. Lucio's phenomenon (Correct Answer)
D. Cutaneous anthrax

Explanation: ### Explanation **Correct Option: C. Lucio’s Phenomenon** Lucio’s phenomenon is a rare, life-threatening variant of a **Type 2 Leprosy Reaction** (though some classify it distinctly). It occurs almost exclusively in patients with **Diffuse Lepromatous Leprosy** (Lucio-Latapi leprosy). * **Pathogenesis:** It involves a severe necrotizing panvasculitis. High bacterial loads lead to direct invasion of endothelial cells by *M. leprae*, triggering immune-mediated vascular occlusion, thrombosis, and subsequent ischemic infarction of the skin. * **Clinical Presentation:** It manifests as painful, erythematous, jagged purpuric patches that evolve into **large, necrotic cutaneous ulcers**, typically appearing after starting multidrug therapy (MDT). **Why Incorrect Options are Wrong:** * **A. Raynaud’s Phenomenon:** A vasospastic disorder causing discoloration of fingers/toes in response to cold or stress; it is not associated with mycobacterial infection or necrotic ulceration. * **B. Placebo Phenomenon:** A psychological or physiological effect following a "sham" treatment; irrelevant to leprosy pathology. * **D. Cutaneous Anthrax:** Caused by *Bacillus anthracis*, it presents as a painless "malignant pustule" with a characteristic central black eschar, not related to chronic leprosy reactions. **High-Yield NEET-PG Pearls:** * **Lucio-Latapi Leprosy:** Characterized by "pure primitive diffuse infiltration," loss of eyebrows/eyelashes (madarosis), and a shiny "moon-face" appearance. * **Geographic Distribution:** Most common in Mexico and Central America. * **Treatment:** While MDT is continued, systemic corticosteroids and intensive wound care are vital. Unlike Erythema Nodosum Leprosum (ENL), Thalidomide is generally **not** effective for Lucio’s phenomenon. * **Histology:** Look for acid-fast bacilli (AFB) within the walls of blood vessels and endothelial cells.

Question 48: What are the characteristics of Type II lepra reaction?

A. Erythema and edema
B. Erythema nodosum leprosum (ENL)
C. Lymphadenopathy
D. All of the above (Correct Answer)

Explanation: **Explanation:** Type II Lepra Reaction, also known as **Erythema Nodosum Leprosum (ENL)**, is a **Type III hypersensitivity reaction** (immune-complex mediated) that typically occurs in patients with multibacillary leprosy (BL and LL types). It is characterized by a systemic inflammatory response due to the deposition of antigen-antibody complexes in various tissues. * **Why Option D is correct:** ENL is a multisystem disorder. The hallmark is the sudden appearance of tender, evanescent, **erythematous** nodules and plaques (**Option A and B**). Because it is a systemic immune response, it frequently involves the reticuloendothelial system, leading to **lymphadenopathy** (**Option C**), fever, malaise, and organ involvement such as neuritis, arthritis, iridocyclitis, and orchitis. * **Analysis of Options:** * **Erythema and edema:** These are local inflammatory signs seen in the skin lesions of ENL. * **ENL:** This is the clinical synonym for Type II reactions. * **Lymphadenopathy:** A common systemic feature reflecting the widespread immune activation. **High-Yield Clinical Pearls for NEET-PG:** * **Trigger:** Often precipitated by chemotherapy (MDT), pregnancy, or stress. * **Timing:** Usually occurs later in the course of treatment compared to Type I reactions. * **Drug of Choice:** **Thalidomide** is the most effective treatment for severe ENL. For mild cases or when thalidomide is contraindicated (e.g., pregnancy), **Prednisolone** or **Clofazimine** (at higher doses) are used. * **Key Difference:** Unlike Type I reactions (Type IV hypersensitivity), Type II reactions do not occur in paucibacillary (TT/BT) leprosy.

Question 49: Which of the following oral structures are not affected in Leprosy?

A. Gingiva (Correct Answer)
B. Tongue
C. Hard Palate
D. Soft Palate

Explanation: **Explanation:** Leprosy, specifically the **Multibacillary (Lepromatous)** spectrum, frequently involves the oral cavity due to the systemic dissemination of *Mycobacterium leprae*. The primary factor determining the site of involvement is **temperature**; the bacilli prefer cooler areas of the body. **Why Gingiva is the correct answer:** The **gingiva** is rarely affected in leprosy. While the oral mucosa can harbor lepromas, the gingival tissue is relatively resistant compared to other oral structures. In clinical practice, even in advanced Lepromatous Leprosy (LL), the gingiva remains largely spared, making it the most appropriate "except" choice for this question. **Analysis of Incorrect Options:** * **Hard Palate:** This is the **most common** site of oral involvement in leprosy. It often presents with chronic congestion, followed by the formation of "lepromas" (nodules) which may ulcerate or lead to perforation. * **Soft Palate and Uvula:** These are frequently involved after the hard palate. Infiltration can lead to scarring, fibrosis, and a "shrunken" appearance of the uvula. * **Tongue:** The tongue is a common site for lepromatous lesions, typically presenting as **"Glossitis centralis"** or nodules on the dorsum. It may also show "cobblestone" appearance or macroglossia. **High-Yield Clinical Pearls for NEET-PG:** * **Most common oral site:** Hard Palate. * **Sequence of involvement:** Hard palate > Soft palate > Tongue > Uvula. * **Temperature Sensitivity:** Oral lesions occur because the air passing through the mouth cools the mucosa, creating an environment below $37^\circ C$ favorable for *M. leprae*. * **Facies Leprosa (Bergen Syndrome):** Includes atrophy of the anterior nasal spine, atrophy of the maxillary alveolar process, and endonasal inflammatory changes.

Question 50: Skin lesions following visceral leishmaniasis typically present as which of the following?

A. Hyperpigmented macules
B. Hypopigmented macules (Correct Answer)
C. Ecchymosis
D. All of the above

Explanation: **Explanation:** The question describes **Post-Kala-Azar Dermal Leishmaniasis (PKDL)**, a non-ulcerative cutaneous manifestation that occurs in patients following the clinical recovery from Visceral Leishmaniasis (Kala-azar), caused by *Leishmania donovani*. **Why Hypopigmented Macules are Correct:** PKDL typically presents in two stages. The earliest and most common presentation is **hypopigmented macules**, which usually start on the face and later spread to the trunk and extremities. These macules are characteristically non-anesthetic (unlike Leprosy). Over time, these may progress into malar erythema, followed by the development of yellowish-pink non-ulcerating nodules or plaques. **Why Other Options are Incorrect:** * **Hyperpigmented Macules:** While Kala-azar itself is known as "Black Fever" due to generalized hyperpigmentation (especially on the hands, feet, and abdomen), the specific dermal sequel (PKDL) is characterized by a loss of pigment (hypopigmentation), not an increase. * **Ecchymosis:** This refers to subcutaneous bleeding/bruising. While Visceral Leishmaniasis can cause thrombocytopenia leading to bleeding tendencies, it is not a characteristic feature of the post-treatment skin lesions (PKDL). **High-Yield Clinical Pearls for NEET-PG:** * **Incidence:** In the Indian subcontinent, PKDL occurs in about 5-10% of cases, usually **2–3 years** after the visceral phase. In Sudan, it occurs in up to 50% of cases, much sooner (weeks to months). * **Diagnosis:** Slit-skin smear or biopsy shows **LD bodies** (Amastigotes), though they are harder to find in macules compared to nodules. * **Treatment:** The drug of choice in India is **Miltefosine** (for 12 weeks) or Amphotericin B. * **Public Health Significance:** Patients with PKDL act as an important **environmental reservoir** for the parasite, as the lesions are highly infectious to sandflies (*Phlebotomus argentipes*).

Question 51: What is the treatment for Lucio phenomenon?

A. Steroids
B. Lenalidomide
C. Clofazimine
D. Exchange transfusion (Correct Answer)

Explanation: ### Explanation **Lucio phenomenon** is a rare, life-threatening variant of Type 2 Lepra reaction (ENL) seen exclusively in patients with **Diffuse Lepromatous Leprosy (Lucio Leprosy)**. **Why Exchange Transfusion is the Correct Answer:** The pathogenesis involves a severe, necrotizing occlusive vasculitis. Large numbers of *M. leprae* invade the endothelial cells of dermal blood vessels, leading to endothelial proliferation, thrombus formation, and subsequent ischemic infarction of the skin. This results in the characteristic "star-shaped" or polygonal necrotic ulcers. Because the condition is driven by a massive bacterial load and circulating immune complexes causing hypercoagulability and systemic toxicity, **Exchange Transfusion** (or Plasmapheresis) is considered the definitive treatment to rapidly clear these mediators and improve survival in severe cases. **Analysis of Incorrect Options:** * **A. Steroids:** While used in standard Type 1 and Type 2 reactions, steroids have limited efficacy in Lucio phenomenon because the primary pathology is thrombotic vasculitis rather than purely inflammatory. * **B. Lenalidomide:** This is a derivative of Thalidomide. While Thalidomide is the drug of choice for standard ENL, it is generally **ineffective** in Lucio phenomenon. * **C. Clofazimine:** This is part of the MDT regimen and has anti-inflammatory properties, but it acts too slowly to manage the acute, life-threatening crisis of Lucio phenomenon. **High-Yield Clinical Pearls for NEET-PG:** * **Geographic distribution:** Most common in Mexico and Central America. * **Clinical hallmark:** Painful, jagged, violaceous purpuric macules that evolve into **polygonal necrotic ulcers**, typically on the extremities. * **Histopathology:** Shows acid-fast bacilli (AFB) within the endothelial cells and "thrombotic vasculitis." * **Mnemonic:** Remember **"Lucio = Lethal"** – it requires aggressive intervention like exchange transfusion, unlike standard ENL which responds to Thalidomide.

Question 52: A boy from Bihar presents with a non-anesthetic, hypopigmented, atrophic patch over his face. What is the diagnosis?

A. Pityriasis alba
B. Pityriasis versicolor
C. Indeterminate leprosy (Correct Answer)
D. Borderline leprosy

Explanation: ### **Explanation** The correct diagnosis is **Indeterminate Leprosy**. This is the earliest clinical stage of leprosy, often seen in children. **1. Why Indeterminate Leprosy is Correct:** * **Clinical Presentation:** It typically presents as a single, poorly defined, **hypopigmented patch**, most commonly on the face, outer arms, or thighs. * **Sensory Findings:** Unlike other forms of leprosy, the patch in the indeterminate stage is often **non-anesthetic** (or has only vague sensory loss) because nerve damage is minimal at this early phase. * **Epidemiology:** The patient is from Bihar, an endemic belt for leprosy in India, which increases clinical suspicion. **2. Why Other Options are Incorrect:** * **Pityriasis alba:** Presents as multiple, scaly, hypopigmented patches with indistinct borders, usually associated with atopy. It does not show atrophy. * **Pityriasis versicolor:** A fungal infection (Malassezia) presenting as multiple small, "dusty" scaly macules. It is diagnosed by a "spaghetti and meatballs" appearance on KOH mount, not by atrophy or endemicity. * **Borderline leprosy:** These lesions are usually multiple, well-defined, and show **definite sensory loss** and nerve enlargement, which are absent in this case. **3. NEET-PG High-Yield Pearls:** * **Fate of Indeterminate Leprosy:** About 75% of cases heal spontaneously; the rest evolve into a specific type (Tuberculoid, Borderline, or Lepromatous) based on the patient's CMI (Cell-Mediated Immunity). * **Histopathology:** Shows a non-specific perivascular and periappendageal lymphocytic infiltrate. Acid-fast bacilli (AFB) are rarely found. * **Key Differentiator:** If a hypopigmented patch on a child's face in an endemic area is non-anesthetic, always suspect Indeterminate Leprosy first.

Question 53: Which among the following organisms causes Buruli ulcer?

A. M. Marinum
B. M. Ulcerans (Correct Answer)
C. M. kansasii
D. M. Smegmatis

Explanation: **Explanation:** **Buruli ulcer** is a chronic, debilitating necrotizing disease of the skin and soft tissue caused by **Mycobacterium ulcerans**. It is the third most common mycobacterial disease in immunocompetent hosts, following tuberculosis and leprosy. 1. **Why M. ulcerans is correct:** * **Pathogenesis:** The hallmark of *M. ulcerans* is the production of a potent polyketide lipid toxin called **Mycolactone**. This toxin has cytotoxic and immunosuppressive properties, leading to extensive tissue necrosis and the characteristic "painless" ulcer with **undermined edges**. * **Transmission:** It is typically associated with slow-moving water bodies (swamps, wetlands), though the exact mode of transmission remains under study (aquatic insects or minor trauma). 2. **Analysis of Incorrect Options:** * **M. marinum:** Causes **Fish Tank Granuloma** or Swimming Pool Granuloma. It typically presents as a localized granulomatous lesion or sporotrichoid spread following exposure to contaminated water or fish. * **M. kansasii:** A photochromogen that primarily causes **pulmonary disease** resembling tuberculosis, though it can occasionally cause skin lesions in immunocompromised patients. * **M. smegmatis:** A rapid-grower (Runyon Group IV) usually considered a commensal or saprophyte, rarely causing skin or soft tissue infections post-surgery or trauma. **High-Yield Clinical Pearls for NEET-PG:** * **Characteristic Feature:** Large, **painless** ulcer with deeply **undermined edges**. * **Toxin:** Mycolactone (essential for virulence). * **Diagnosis:** PCR is the gold standard (IS2404 target). * **Treatment:** WHO recommends a combination of **Rifampicin and Clarithromycin** (or Streptomycin) for 8 weeks. * **Geographic Distribution:** Most common in West and Central Africa (e.g., Benin, Côte d'Ivoire).

Question 54: The 'groove sign' is characteristic of which condition?

A. Syphilis
B. Dermatomyositis
C. Lymphogranuloma venereum (LGV) (Correct Answer)
D. Systemic lupus erythematosus (SLE)

Explanation: ### Explanation **1. Why the Correct Answer is Right:** The **'Groove Sign' (Greenblatt’s Sign)** is a pathognomonic clinical finding in **Lymphogranuloma venereum (LGV)**, caused by *Chlamydia trachomatis* (serovars L1, L2, L3). It occurs during the secondary stage of the disease when the inguinal and femoral lymph nodes enlarge simultaneously. These two groups of nodes are separated by the **Poupart’s (inguinal) ligament**, which creates a visible depression or "groove" between the matted clusters of lymph nodes. **2. Why the Other Options are Wrong:** * **Syphilis:** Characterized by a painless, indurated ulcer (chancre) in the primary stage and a generalized maculopapular rash in the secondary stage. Lymphadenopathy is typically bilateral and non-suppurative, without a groove sign. * **Dermatomyositis:** A rheumatological condition characterized by Gottron papules, Heliotrope rash, and proximal muscle weakness. It does not involve suppurative inguinal lymphadenopathy. * **Systemic Lupus Erythematosus (SLE):** Presents with a malar rash, photosensitivity, and multi-organ involvement. While lymphadenopathy can occur, it is non-specific and does not form the characteristic groove sign. **3. Clinical Pearls for NEET-PG:** * **Causative Agent:** *Chlamydia trachomatis* L1-L3 (obligate intracellular). * **Stages of LGV:** 1. *Primary:* Small, painless, transient papule/ulcer. 2. *Secondary (Inguinal Syndrome):* Painful "buboes" and the **Groove Sign**. 3. *Tertiary (Genito-anorectal Syndrome):* Proctocolitis, strictures, and elephantiasis (Esthiomene). * **Treatment of Choice:** Doxycycline (100 mg BID for 21 days). Erythromycin is the alternative for pregnant patients. * **Differential Diagnosis:** Don't confuse the "Groove Sign" with the "School of Fish" appearance (Chancroid) or "Donovan bodies" (Granuloma Inguinale).

Question 55: A 65-year-old beggar comes to your OPD with following presentation in upper part of foot Gram stain of discharge was performed. All are true about the condition shown except:

A. Massive inguinal lymphadenopathy (Correct Answer)
B. Most common site is dorsum of foot
C. Granules are aggregates of organized vegetative, septate hyphae
D. Amphotericin B has limited role in eumycetoma

Explanation: ***Massive inguinal lymphadenopathy*** - Mycetoma typically has **minimal or no lymph node involvement**, even with extensive lesions. - The lack of significant lymphatic spread is a characteristic feature that differentiates it from other chronic inflammatory conditions. *Most common site is dorsum of foot* - The **foot**, particularly the **dorsum**, is indeed the most common site for mycetoma due to trauma and direct inoculation. - This anatomical location is highly exposed to the environment, increasing the risk of spore implantation. *Granules are aggregates of organized vegetative, septate hyphae* - Mycetoma is characterized by the presence of **"granules"** within the lesions, which are indeed **compact aggregates of fungal hyphae** (for eumycetoma) or bacterial filaments (for actinomycetoma). - These granules can be visualized in discharge or biopsy and are crucial for diagnosis and differentiating between eumycetoma and actinomycetoma. *Amphotericin B has limited role in eumycetoma* - **Amphotericin B** is generally **ineffective** against most causes of eumycetoma, which are difficult to treat with antifungals. - Treatment for eumycetoma often requires more aggressive, **long-term therapy with azoles** (e.g., voriconazole, itraconazole) and surgical debridement, highlighting the limited utility of Amphotericin B.

Question 56: A young male presented with an anesthetic patch on the right forearm. A thickened nerve was palpable on examination. Skin biopsy shows the image below. What is the diagnosis?

A. TT
B. LL (Correct Answer)
C. Histiocytosis
D. Lymphoma

Explanation: ***LL*** - The image shows a **granuloma with foamy macrophages** (Virchow cells) laden with bacilli, characteristic of **lepromatous leprosy (LL)**. The accompanying clinical features of an anesthetic patch and thickened nerve point towards leprosy. - In LL, there is **poor cell-mediated immunity** with a predominant **Th2 response**, leading to ineffective control of intracellular *Mycobacterium leprae*. While **humoral immunity** is increased, it is ineffective against the intracellular pathogen, resulting in widespread bacterial multiplication and the characteristic **foamy macrophages** (Virchow cells) laden with bacilli. *TT* - **Tuberculoid leprosy (TT)** would typically show a well-formed, epithelioid granuloma with few or no bacilli, reflecting a strong cell-mediated immune response. - Clinical presentation involves well-demarcated, anesthetic patches with significant nerve damage, but the biopsy features would differ from those seen here. *Histiocytosis* - **Histiocytosis** refers to a group of disorders involving abnormal proliferation of histiocytes/macrophages, such as Langerhans cell histiocytosis. - While it involves macrophages, the specific morphology and clinical presentation (anesthetic patch, thickened nerve) are not typical for histiocytosis. *Lymphoma* - **Lymphoma** involves the malignant proliferation of lymphocytes and would present with atypical lymphoid infiltrates, not the macrophage-rich granulomas seen in the image. - The clinical context of an anesthetic patch and thickened nerve is also not characteristic of primary cutaneous lymphoma.

Question 57: All are true about the lesion shown except:

A. HHV-7
B. Herald patch
C. Predominantly occurs on genitals (Correct Answer)
D. Spontaneous healing

Explanation: ***Predominantly occurs on genitals*** - The image shows a rash consistent with **Pityriasis rosea**, which typically affects the **trunk and proximal extremities**, sparing the face, palms, and soles. - While individual lesions can appear anywhere on the body, the generalized distribution seen here is **not typically genital-predominant**. *HHV-7* - **Pityriasis rosea** is strongly associated with active infection or reactivation of **human herpesvirus 7 (HHV-7)**, and sometimes HHV-6. - Research suggests a causal link, although the exact pathogenic mechanism is still being investigated. *Herald patch* - **Pityriasis rosea** typically begins with a solitary, larger lesion known as a **herald patch** or mother patch, which precedes the generalized eruption by several days or weeks. - This initial lesion is often oval or circular and can be mistaken for other skin conditions. *Spontaneous healing* - **Pityriasis rosea** is a self-limiting rash that usually resolves spontaneously within **6-8 weeks** without specific treatment. - Although the rash can be itchy, the prognosis is excellent, and it rarely recurs.

Question 58: A patient lives in an urban slum and practices open-air defecation. He presented with continuous itching over the sole. The image shows presence of:

A. Cutaneous larva migrans (Correct Answer)
B. Ecthyma
C. Erysipelas
D. Migratory myiasis

Explanation: ***Cutaneous larva migrans*** - The image shows **serpiginous, erythematous, and highly pruritic lesions** on the sole, which are characteristic of cutaneous larva migrans. - The patient's history of living in an urban slum and engaging in **open-air defecation** indicates exposure to soil contaminated with **hookworm larvae**, which penetrate the skin and cause these migratory tracks. *Ecthyma* - Ecthyma is a **bacterial skin infection** characterized by **crusted, ulcerative lesions** that extend into the dermis. - It does not present with the characteristic **migratory, linear tracks** seen in the image. *Erysipelas* - Erysipelas is a **superficial bacterial infection** of the dermis with significant lymphatic involvement, presenting as a **sharply demarcated, erythematous, raised rash** with fever and systemic symptoms. - It does not cause the **linear, tunneling appearance** observed in the provided image. *Migratory myiasis* - Myiasis involves infection with **fly larvae** (maggots) that infest living tissue. While some forms of myiasis can be migratory, they typically present as **boil-like lesions** with a central pore, or as subcutaneous nodules, which is different from the **serpiginous tracks** of cutaneous larva migrans. - The source of infection (contaminated soil with hookworm larvae) points away from fly larvae.

Question 59: The image shows:

A. Neuropathic ulcer
B. Myrmecia
C. Madura foot (Correct Answer)
D. Sporotrichosis

Explanation: ***Madura foot*** - The image shows multiple **sinuses** and **abscesses** with evidence of pus discharge on a swollen, deformed foot, which is characteristic of **Madura foot** or **mycetoma**. - This condition is a chronic granulomatous infection of subcutaneous tissues, often caused by **fungi (eumycetoma)** or **bacteria (actinomycetoma)**, and typically affects the foot after minor trauma. *Neuropathic ulcer* - **Neuropathic ulcers** are typically well-demarcated, painless ulcers occurring on pressure points of the foot, often surrounded by calloused skin, and usually present as single lesions. - They do not typically present with the widespread inflammatory swelling, multiple sinuses, and granule discharge seen in the image. *Myrmecia* - **Myrmecia** refers to a specific type of common wart caused by **Human Papillomavirus (HPV)**, characterized by a single, large, deep lesion with surrounding smaller satellite warts. - This condition is a dermal lesion and does not involve the widespread tissue destruction, multiple draining sinuses, and swelling associated with Madura foot. *Sporotrichosis* - **Sporotrichosis** is a subcutaneous fungal infection that often presents as a **lymphocutaneous spread**, with a primary ulcer or nodule and a chain of secondary nodules along lymphatic channels. - While it can cause skin lesions, it typically does not present with the extensive osteomyelitis, soft tissue destruction, and characteristic "grains" or sinus tracts seen in advanced Madura foot.

Question 60: A 53 year-old male presented with erythematous, edematous plaques on his face over pre-existing hypoesthetic patches. He has been experiencing pain for the last 10 days and has been on multibacillary multidrug therapy (MBMDT) for leprosy for the past two months. What is the most likely diagnosis based on the image?

A. Type 1 Lepra reaction (Correct Answer)
B. Erythema Nodosum Leprosum (ENL)
C. Cellulitis of the face
D. Erysipelas

Explanation: ***Type 1 Lepra reaction*** - The patient presents with **erythematous, edematous plaques on pre-existing hypoesthetic patches** on the face, along with pain and current treatment with **multibacillary multidrug therapy (MBMDT)**. This clinical picture is classic for a type 1 lepra reaction, which is a **delayed-type hypersensitivity reaction** to *Mycobacterium leprae* antigens, often seen during or after treatment. - The image shows significant **facial edema** and **erythema**, particularly around the eyes and nose, consistent with the acute inflammation of a type 1 reaction affecting existing skin lesions and nerves, leading to pain. *Erythema Nodosum Leprosum (ENL)* - ENL is a **Type 2 lepra reaction**, characterized by the appearance of **painful, tender, erythematous nodules** over normal skin, often affecting the limbs and trunk, not typically pre-existing hypoesthetic patches. - It is an **immune complex-mediated reaction** and usually presents more acutely with systemic symptoms like fever and malaise, along with the characteristic nodules, which are not primarily visible in the photograph as widespread edematous plaques. *Cellulitis of the face* - Cellulitis is a **bacterial infection** of the deep dermis and subcutaneous tissue, presenting as a **spreading, warm, red, tender area** with poorly defined borders, often associated with fever and lymphadenopathy. - While there is erythema and edema, the chronic nature of the underlying hypoesthetic patches, the patient's history of leprosy, and the specific distribution suggest a reaction related to leprosy rather than a typical acute bacterial infection. *Erysipelas* - Erysipelas is a **superficial bacterial skin infection**, typically caused by *Streptococcus pyogenes*, characterized by a **sharply demarcated, raised, red, warm, and tender plaque**, often on the face, with characteristic "peau d'orange" texture. - Although it causes facial erythema and edema, the clearly defined borders of erysipelas are not evident, and the association with pre-existing hypoesthetic patches in a leprosy patient points more strongly towards a lepra reaction.

Question 61: A 12-week pregnant woman on multidrug therapy for leprosy presents with type 2 lepra reaction. What is the treatment of choice for this patient?

A. Continue MDT and add oral steroids (Correct Answer)
B. Antibiotics
C. Stop MDT and start oral steroids
D. Thalidomide

Explanation: ***Continue MDT and add oral steroids*** - **Type 2 lepra reactions (erythema nodosum leprosum)** are inflammatory complications of leprosy and require systemic anti-inflammatory treatment. **Oral corticosteroids** are the mainstay for managing these reactions, particularly in pregnant patients where other immunomodulators are contraindicated. - **Multidrug therapy (MDT)** for leprosy should be continued throughout the reaction, even during pregnancy, to ensure eradication of <b>*Mycobacterium leprae*</b> and prevent drug resistance. Interrupting MDT can lead to relapse and increased neurological damage. *Antibiotics* - This option is incorrect because the type 2 lepra reaction is an **immunological complication** of leprosy, not a bacterial infection requiring additional antibiotics beyond the standard MDT. - The symptoms are due to the immune system's response to dying bacteria, not a new or secondary bacterial infection. *Stop MDT and start oral steroids* - Stopping MDT is inappropriate as the underlying **leprosy infection** still needs to be treated to prevent further progression and drug resistance. - While steroids are crucial for managing the reaction, stopping MDT would compromise the **curative treatment** for leprosy. *Thalidomide* - **Thalidomide** is highly effective in treating **erythema nodosum leprosum (ENL)**. - However, it is an absolute **contraindication** during pregnancy due to its severe **teratogenicity**, causing severe birth defects.

Question 62: Single skin lesion is seen in which type of leprosy -

A. LL
B. TT (Correct Answer)
C. BL
D. BT

Explanation: ***TT*** - **Tuberculoid leprosy (TT)** is characterized by a strong cell-mediated immune response, leading to a **single, well-demarcated skin lesion** with clear borders and sensory loss. - The few bacilli present are kept localized, preventing widespread dissemination and multiple lesions. *LL* - **Lepromatous leprosy (LL)** is associated with a weak cell-mediated immune response, resulting in **numerous, poorly defined lesions**, nodules, and widespread infiltration. - The high bacillary load leads to systemic involvement and many lesions rather than a single one. *BL* - **Borderline lepromatous (BL)** leprosy is an unstable form with features between borderline tuberculoid and lepromatous, presenting with **multiple, widespread lesions** often with varying sizes and sensory loss. - While skin lesions are present, they are typically numerous and polymorphic, not a single lesion. *BT* - **Borderline tuberculoid (BT)** leprosy presents with **few to several skin lesions**, which are usually smaller, less well-defined, and more numerous than in TT leprosy. - Although closer to TT, it generally involves more than one lesion and exhibits less pronounced sensory loss compared to the single, anesthetic lesion of TT.

Question 63: Multiple hypoaesthetic, hypopigmented macules on right lateral forearm with numerous acid-fast bacilli is indicative of:

A. Borderline leprosy
B. Tuberculoid leprosy
C. Lepromatous leprosy (Correct Answer)
D. Indeterminate leprosy

Explanation: ***Lepromatous leprosy*** - The hallmark feature is **numerous acid-fast bacilli (AFB)** in skin smears, indicating a **high bacterial load** characteristic of lepromatous leprosy (bacterial index 4-6+). - Lepromatous leprosy is **multibacillary** with **poor cell-mediated immunity**, allowing uncontrolled bacterial multiplication (10⁶-10⁹ bacilli per gram of tissue). - While typically presenting with **widespread, symmetrical lesions**, early lepromatous leprosy can present with **multiple hypopigmented macules** before progressing to diffuse infiltration. - **Sensory loss** may be present but is typically **less pronounced** initially compared to tuberculoid leprosy, as nerve damage occurs gradually. *Borderline leprosy* - Represents the **unstable middle spectrum** (BT, BB, BL) with **moderately impaired immunity** and **variable bacterial load**. - Borderline tuberculoid (BT) has **few AFB**, borderline lepromatous (BL) has **moderate AFB**, but the term "numerous AFB" more specifically indicates lepromatous leprosy. - Lesions are typically **asymmetrical** with variable sensory loss depending on the subtype. *Tuberculoid leprosy* - Characterized by **paucibacillary disease** with **strong cell-mediated immunity** that effectively contains bacterial proliferation. - Skin smears show **few or no detectable AFB** (bacterial index 0-1+) due to robust immune response. - Presents with **few well-defined lesions (1-5)** with **marked sensory loss** and thickened nerves. *Indeterminate leprosy* - The **earliest stage** of leprosy, presenting as a **single hypopigmented or erythematous macule** with minimal sensory changes. - Shows **few or no AFB** on skin smears and may evolve into any form of leprosy or resolve spontaneously. - Not consistent with multiple lesions and numerous bacilli.

Question 64: A 45-year-old male had multiple hypoesthetic, mildly erythematous large plaques with elevated margins on trunk and extremities. His ulnar and lateral popliteal nerves on both sides were enlarged. The most probable diagnosis is:

A. Borderline lepromatous leprosy
B. Lepromatous leprosy
C. Borderline leprosy
D. Borderline tuberculoid leprosy (Correct Answer)

Explanation: ***Borderline tuberculoid leprosy*** - The clinical presentation of **multiple hypoesthetic, large plaques with elevated margins** is characteristic of **BT leprosy**, which features **well-demarcated lesions with raised, sloping edges** - **Prominent bilateral nerve enlargement** (ulnar and lateral popliteal nerves) with relatively **few to moderate lesions** is a hallmark of BT leprosy - BT shows **strong cell-mediated immunity** resulting in well-defined plaques with **marked hypoesthesia** and **asymmetric nerve involvement** - The **mildly erythematous** appearance and **elevated margins** indicate active cellular immune response typical of the tuberculoid end of the spectrum *Borderline lepromatous leprosy* - BL presents with **numerous, poorly demarcated lesions** (many more than described) including dome-shaped plaques, papules, and nodules - Lesions in BL have **punched-out centers** rather than elevated margins - Nerve involvement is less prominent relative to the **high number of skin lesions** - The description of well-demarcated plaques with elevated margins points away from the lepromatous pole *Lepromatous leprosy* - LL shows **numerous, diffuse, symmetrical lesions** that are poorly demarcated (macules, papules, nodules, diffuse infiltration) - Lesions are **not hypoesthetic** in early stages due to preserved sensory function until late nerve damage - No elevated margins; lesions are typically smooth, shiny, and dome-shaped *Borderline leprosy* - This is **mid-borderline (BB)** leprosy, which presents with **moderate to numerous lesions** that are more uniform and less well-demarcated than BT - BB has **dimorphous** features without the clear plaques with elevated margins described - The clinical description of elevated margins and prominent nerve involvement with moderate lesion count is more specific for BT

Question 65: Punched out lesion or inverted saucer appearance are characteristic of which type of leprosy?

A. Tuberculoid
B. Borderline tuberculoid
C. Lepromatous (Correct Answer)
D. Borderline lepromatous

Explanation: ***Lepromatous*** - **Punched-out lesions**, also known as "inverted saucer appearance," are characteristic of **lepromatous leprosy** due to extensive dermal infiltration and destruction by *Mycobacterium leprae*. - This form of leprosy involves a **weak cellular immune response** allowing widespread bacterial dissemination and visible skin lesions. *Tuberculoid* - Tuberculoid leprosy is characterized by a **strong cell-mediated immune response**, resulting in few, well-demarcated skin lesions with sensory loss. - It is typically **paucibacillary**, meaning few bacteria are present in the lesions, and does not cause punched-out or inverted saucer appearances. *Borderline tuberculoid* - Borderline tuberculoid leprosy presents with **moderate cell-mediated immunity** and a few skin lesions that are more numerous and less well-defined than in tuberculoid leprosy. - While it can be more extensive than tuberculoid, it typically does not exhibit the extensive tissue destruction leading to "punched-out" lesions characteristic of the lepromatous pole. *Borderline lepromatous* - Borderline lepromatous leprosy shows a **weak cellular immune response** and numerous, ill-defined lesions, often with varying sizes and shapes. - While it shares some features of lepromatous leprosy, the classic "punched-out" or "inverted saucer" appearance is more specifically associated with the widespread and uniform dermal infiltration of **full-blown lepromatous leprosy**.

Question 66: Type-II lepra reaction is most commonly found in:

A. BL
B. LL (Correct Answer)
C. BT
D. None of the options

Explanation: ***LL*** - **Type 2 lepra reactions (ENL)** are most commonly seen in the **lepromatous spectrum** of leprosy, particularly in **LL (lepromatous leprosy)** and sometimes in **BL (borderline lepromatous) leprosy**. - These reactions are an **immune complex-mediated hypersensitivity reaction** to M. leprae antigens, leading to acute inflammation. *BL* - While **Type II lepra reactions (ENL)** can occur in **borderline lepromatous (BL) leprosy**, they are **less frequent** and generally less severe than in LL. - Patients with BL leprosy are more prone to **Type I lepra reactions (reversal reactions)**, reflecting shifts in cell-mediated immunity. *BT* - **Borderline tuberculoid (BT) leprosy** patients primarily experience **Type I lepra reactions (reversal reactions)**, which are cell-mediated immune responses. - **Type II lepra reactions (ENL)** are generally **not seen** in the tuberculoid spectrum due to the robust cell-mediated immunity. *None of the options* - This option is incorrect because **LL (lepromatous leprosy)** is a well-established and common site for Type II lepra reactions. - The other options represent different classifications within the leprosy spectrum, and LL is indeed recognized for this specific reaction.

Question 67: Delhi boil refers to:

A. Solar Keratosis
B. Venereal ulcer
C. Malignant pustule
D. L. tropica sore (Correct Answer)

Explanation: ***L. tropica sore*** - Delhi boil is a common name for cutaneous **leishmaniasis**, specifically caused by **Leishmania tropica**. - This condition presents as a **skin lesion** or sore, primarily in endemic regions like Delhi. *Solar Keratosis* - Solar keratosis is a **precancerous skin lesion** caused by long-term exposure to ultraviolet (UV) radiation from the sun. - It presents as a **rough, scaly patch** on sun-exposed areas and is not associated with parasitic infection. *Venereal ulcer* - A venereal ulcer is a **genital sore** typically caused by sexually transmitted infections (STIs) such as syphilis, herpes, or chancroid. - These ulcers are localized to the genital area and have a different etiology and clinical presentation than Delhi boil. *Malignant pustule* - A malignant pustule is a term sometimes used historically to describe **anthrax skin lesions** due to their necrotic and often black center, but more generally refers to a pustular lesion with malignant or highly aggressive characteristics. - It is not a synonym for Delhi boil, which is a parasitic infection with a distinct clinical course and etiology.

Question 68: What factors contribute to the higher prevalence of tinea versicolor in tropical climates?

A. Increased sweating promotes fungal growth (Correct Answer)
B. Fungal spores are commonly found in tropical environments
C. UV exposure suppresses local skin immunity
D. Higher humidity levels facilitate fungal growth

Explanation: ***Increased sweating promotes fungal growth*** - **Malassezia**, the causative fungus of tinea versicolor, is **lipophilic** and thrives in warm, moist environments with increased sebum production - **Increased sweating** in tropical climates creates the optimal combination of **moisture, warmth, and lipid availability** on the skin surface, directly promoting fungal proliferation and conversion from commensal to pathogenic form - This is the **most direct and specific mechanism** linking tropical climates to tinea versicolor prevalence, as sweat provides both moisture and alters the skin pH favorable for *Malassezia* overgrowth *Incorrect: Fungal spores are commonly found in tropical environments* - *Malassezia* is a **normal commensal organism** found on human skin worldwide, not specifically in tropical environments - The organism's presence alone does not explain increased disease prevalence; rather, **environmental triggers** (heat, humidity, sweating) cause the transition from commensal to pathogenic state - Disease prevalence is determined by host and environmental factors, not mere presence of the organism *Incorrect: UV exposure suppresses local skin immunity* - While UV exposure can have immunosuppressive effects, this is **not the primary mechanism** for increased tinea versicolor in tropical regions - UV exposure actually makes the characteristic **hypopigmented lesions more noticeable** as surrounding skin tans while affected areas remain pale - There is no direct causal relationship between UV exposure and *Malassezia* overgrowth *Incorrect: Higher humidity levels facilitate fungal growth* - While humidity does contribute to favorable conditions for fungal growth, it is a **less specific factor** compared to increased sweating - Humidity alone without the accompanying **increased sweating, sebum production, and skin surface changes** is insufficient to fully explain the prevalence - The **combination of heat-induced sweating** with humidity is the key factor, making "increased sweating" the more comprehensive and direct answer

Question 69: In Ainhum, constriction develops usually at the level of the interphalangeal joint of which toe?

A. Great toe
B. 2nd toe
C. 4th toe
D. 5th toe (Correct Answer)

Explanation: ***5th toe*** - **Ainhum** is a condition characterized by progressive concentric constrictions, typically leading to autoamputation. - It most commonly affects the **fifth digit of the foot** (little toe), at the level of the **interphalangeal joint**. - The characteristic constriction band typically begins on the **plantar-medial aspect** of the fifth toe. *Great toe* - While other toes can be affected, the great toe is less commonly involved in Ainhum. - The disease shows a strong predilection for the lateral digits, particularly the fifth toe. *2nd toe* - The second toe is not the most common digit for the constriction band to develop in Ainhum. - The progression of the disease occurs more frequently in the outermost digits. *4th toe* - While the fourth toe can occasionally be affected, it is much less common than the fifth toe. - Ainhum demonstrates a characteristic pattern favoring the fifth toe in over 90% of cases.

Question 70: In which condition is an ulceronecrotic nodule typically observed?

A. Lucio's leprosy (Correct Answer)
B. Lepromatous leprosy
C. Indeterminate leprosy
D. Histoid leprosy

Explanation: ***Lucio's leprosy*** - This is a rare, diffuse variant of **lepromatous leprosy** characterized by widespread, diffuse infiltration of the skin without distinct nodules. - The distinctive feature is the occurrence of **necrotizing vasculitis**, leading to painful, irregular ulcers and scars, known as **Lucio phenomenon** or erythema necroticans. *Lepromatous leprosy* - Characterized by **multiple, symmetrical nodules**, plaques, and diffuse infiltration, but typically without the profound ulceronecrotic changes seen in Lucio's leprosy. - The immune response is weak, leading to high bacterial load and widespread involvement, but usually not spontaneous ulceration. *Indeterminate leprosy* - This is an **early, undifferentiated form** of leprosy, characterized by a single or a few hypopigmented or erythematous macules. - Distinct nodules or ulceronecrotic lesions are not a feature of indeterminate leprosy, as the disease has not yet progressed to develop specific clinical manifestations. *Histoid leprosy* - A rare variant of lepromatous leprosy that presents with **cutaneous nodules** and papules that often resemble dermatofibromas or xanthomas. - These nodules are firm, smooth, and have a unique histological appearance, but they do not typically undergo spontaneous ulceronecrotic changes like those in Lucio's leprosy.

Question 71: 26-year-old man from Bihar presents with erythematous papules on the face and back of the neck, which are hypopigmented and normoaesthetic, with no nerve thickening. A history of prolonged fever in childhood is present. What is the diagnosis?

A. Tuberculoid leprosy
B. Lepromatous leprosy
C. Lupus vulgaris
D. Dermal leishmaniasis (PKDL) (Correct Answer)

Explanation: ***Dermal leishmaniasis (PKDL)*** - PKDL presents with **erythematous papules** on the face and neck, which are **hypopigmented and normoaesthetic** (intact sensation), fitting the patient's description perfectly. - A history of **prolonged fever in childhood** in Bihar is highly suggestive of prior **visceral leishmaniasis (kala-azar)**, after which PKDL typically develops (months to years post-treatment). - The **absence of nerve thickening** and **normal sensation** are key features distinguishing PKDL from leprosy. - Bihar is an **endemic area** for visceral leishmaniasis in India. *Tuberculoid leprosy* - Characterized by **hypopigmented, anaesthetic patches** with **thickened nerves** - both features are absent in this case. - The **normoaesthetic** nature of lesions here rules out tuberculoid leprosy. - Lesions are typically **well-demarcated** and few in number. *Lepromatous leprosy* - Involves widespread, symmetrical lesions that are often **erythematous nodules** or **diffuse infiltrations**, with multiple nerve involvements. - Would show **nerve thickening** and eventual sensory loss, which are not present here. - The clinical picture does not match lepromatous leprosy. *Lupus vulgaris* - A form of **cutaneous tuberculosis** presenting as red-brown plaques with an **"apple-jelly" appearance** on diascopy. - While it can occur on the face, there is no history of fever or connection to visceral leishmaniasis. - The morphology (papules vs plaques) and epidemiological context favor PKDL.

Question 72: A 35-year-old female presented with multiple inverted saucer-shaped ulcers over the body, with sensations near normal. The SSS test was positive, and the lepromin test was negative. What is the most appropriate management for this patient?

A. T.Rifampicin 600 mg and T.Clofazimine 300 mg once a month, T.Clofazimine 100 mg daily, and T.Dapsone 100 mg daily for 12 months.
B. T.Rifampicin 600 mg and T.Clofazimine 300 mg once a month, T.Clofazimine 50 mg daily, and T.Dapsone 100 mg daily for 6 months.
C. T.Rifampicin 600 mg and T.Clofazimine 300 mg once a month, T.Clofazimine 50 mg daily, and T.Dapsone 1000 mg daily for 12 months.
D. T.Rifampicin 600 mg and T.Clofazimine 300 mg once a month, T.Clofazimine 50 mg daily, and T.Dapsone 100 mg daily for 12 months. (Correct Answer)

Explanation: ***Correct WHO MDT-MB regimen (Rifampicin 600 mg + Clofazimine 300 mg monthly, Clofazimine 50 mg daily, Dapsone 100 mg daily for 12 months)*** - The clinical presentation (multiple inverted saucer-shaped ulcers, near normal sensations, positive **SSS test**, negative **lepromin test**) is characteristic of **lepromatous leprosy** (multibacillary leprosy). - The standard WHO-recommended multidrug therapy (MDT) for multibacillary leprosy is **Rifampicin 600 mg once monthly**, **Clofazimine 300 mg once monthly** plus **50 mg daily**, and **Dapsone 100 mg daily for 12 months**. - This regimen ensures adequate bacterial clearance and prevents relapse in multibacillary cases. *Incorrect: Clofazimine 100 mg daily dose* - The daily dose of **Clofazimine** (100 mg) is incorrect, as the standard daily dose for multibacillary leprosy is **50 mg**, not 100 mg. - While other components (Rifampicin, Dapsone doses) and 12-month duration are correct, the incorrect daily clofazimine dose makes this option unsuitable. *Incorrect: 6-month duration* - The duration of treatment for multibacillary leprosy is **12 months**, not 6 months. - A 6-month regimen is indicated for **paucibacillary leprosy** only. - Inadequate treatment duration increases the risk of **relapse and drug resistance** in multibacillary cases. *Incorrect: Dapsone 1000 mg daily dose* - The daily dose of **Dapsone** (1000 mg) is significantly higher than the recommended **100 mg daily**, risking severe toxicity. - High doses of Dapsone can lead to **hemolytic anemia**, **methemoglobinemia**, and other serious adverse effects.

Question 73: The patient with leprosy had slightly erythematous, anesthetic plaques on the trunk and upper limbs. He was treated with paucibacillary multidrug therapy (PB-MDT) for 6 months. At the end of 6 months, he had persistent erythema and induration in the plaque. According to the World Health Organization (WHO) guidelines, what is the next recommended step of action for this patient?

A. Stop antileprosy treatment (Correct Answer)
B. Continue PB-MDT till erythema subsides
C. Biopsy the lesion to document activity
D. Continue dapsone alone for another 6 months

Explanation: ***Stop antileprosy treatment*** - According to **WHO guidelines**, paucibacillary multidrug therapy (PB-MDT) has a **fixed duration of 6 months**, after which treatment should be **stopped regardless of clinical appearance** of the lesions. - The persistent erythema and induration after completing 6 months of PB-MDT represent a **Type 1 lepra reaction (reversal reaction)**, which is an **immunological phenomenon**, not active disease requiring continued antimicrobial therapy. - **Type 1 reactions** should be managed with **corticosteroids (prednisolone 40-60 mg/day)**, not by prolonging MDT, as reactions are inflammatory rather than infectious in nature. - Continuing MDT beyond the recommended duration does **not prevent or treat lepra reactions** and unnecessarily exposes the patient to **drug toxicity and side effects**. *Continue PB-MDT till erythema subsides* - This is **not recommended by WHO guidelines**, which specify a **fixed duration** for PB-MDT (6 months) that should not be extended based on residual erythema or induration. - Persistent inflammation after completing treatment represents a **lepra reaction**, which is managed with **corticosteroids**, not continued MDT. - Extending MDT beyond 6 months for PB cases has no proven benefit and increases risk of **adverse drug reactions** without improving outcomes. *Biopsy the lesion to document activity* - While biopsy could provide histological information, the clinical scenario clearly describes a **Type 1 lepra reaction** occurring at the end of treatment. - The **diagnosis of Type 1 reaction is clinical**, based on erythema, induration, and tenderness in existing lesions after or during treatment. - Biopsy would only delay appropriate management with **corticosteroids** and is not necessary when clinical features are typical. *Continue dapsone alone for another 6 months* - **Monotherapy with dapsone** is absolutely contraindicated in leprosy management due to high risk of **drug resistance**. - After completing the fixed 6-month PB-MDT regimen, **no further antimicrobial therapy is indicated** for paucibacillary leprosy. - The persistent inflammation requires management of the **lepra reaction with corticosteroids**, not continued antimicrobial therapy.

Practice by Chapter

Cutaneous Leishmaniasis

Practice Questions

Leprosy

Practice Questions

Tropical Ulcers

Practice Questions

Onchocerciasis

Practice Questions

Filariasis

Practice Questions

Tropical Mycoses

Practice Questions

Cutaneous Larva Migrans

Practice Questions

Tungiasis

Practice Questions

Myiasis

Practice Questions

Cutaneous Manifestations of Malaria

Practice Questions

Dengue and Other Viral Hemorrhagic Fevers

Practice Questions

Global Health Perspectives in Dermatology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free